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ABSTRACT
The purpose of this study was to investigate whether the cognitive model of panic may explain the 
high levels of anxiety that have been reported amongst people with Chronic Obstructive 
Pulmonary Disease (COPD) (Carr et al, 1994). In previous research, cognitive variables, assessed 
on general measures of catastrophizing (such as the Agoraphobic Cognitions Questionnaire), have 
been shown to be strongly predictive of anxiety in people with COPD, regardless of severity or 
duration of the respiratory disease. One of the aims of this study was to develop a questionnaire 
to elicit specific cognitions in response to a range of COPD-related symptoms presented in 
different situations. Favourable reliability and validity were demonstrated for the questionnaire, 
and its completion by 37 people with COPD produced a range of cognitions of differing severity. 
High levels of anxiety (assessed using the Hospital Anxiety and Depression scale) were found in 
the group (more than 27%). More severe catastrophic thoughts were found to be strongly 
predictive of greater anxiety, particularly for specific anxiety ratings on the new questionnaire, and 
this relationship was more significant when cognitions and anxiety wore elicited by symptoms 
presented in 'unsafe' situations. Severity and duration of illness were not significant predictors of 
anxiety, but social support was strongly predictive of generalized anxiety. In the light of the 
adverse consequences of anxiety with regards to appropriate coping with respiratory disease, an 
exploration of the use of cognitive techniques in therapy is suggested.
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Section 1
INTRODUCTION
1. INTRODUCTION
Respiratory disorders, such as asthma, emphysema, and chronic bronchitis, which result in 
chronic breathing difficulties, represent a major medical and social problem in Europe and the 
USA today (Carr, Lehrer, Rausch, & Hochron, 1994; Kaptein, Dekker, Van der Waart, & Gill, 
1988). The Health of the Nation document specifically identified asthma as a substantial cause 
of ill health, with national targets likely to be set for respiratory health in the future (HMSO,
1991). A number of studies have reported that patients suffering from respiratory disorders show 
higher levels of psychological disturbance than those in the general population, with reports of 
significant emotional, behavioural, and psychosocial deficits (Bums & Howell, 1969; Carr, 
Lehrer & Hochron, 1995; Greenberg, Ryan, & Bourlier, 1985; Porzelius, Vest, & Nochomovitz,
1992), although the exact nature and prevalence of these problems is unclear and research is still 
relatively new in this area. In recent years, clinicians and researchers have identified the 
potential importance of psychological aspects of respiratory diseases in the treatment and 
management of these problems. For example, the literature suggests that high levels of anxiety, 
depression and social isolation amongst this population may contribute to inappropriate over-use 
of medication, and more frequent hospital admissions (Carr et a l, 1995; Kinsman, Dirks, Jones 
& Dahlem, 1980; Lehrer, Sargunaraj, & Hochron, 1992).
Following a brief explanation of general characteristics of chronic breathing disorders, there will 
be a discussion of research studies which have looked at the prevalence of anxiety and panic in 
this population. Although depression is also a feature often reported in studies with patients with 
respiratory impairment (Lehrer et a l, 1992) it will not be a major focus of this study. Various 
models that could account for reportedly high levels of anxiety in people with respiratory disease
are presented briefly, with discussion of factors that provide evidence for and against each 
model. Particular emphasis will be given to the application of cognitive theory to the experience 
of anxiety and panic, and the limitations of the research to date, in providing firm evidence for or 
against this theory.
1.1 DEFINITION OF RESPIRATORY DISORDERS
1.1.1 Chronic Obstructive Pulmonary Disease (COPD) refers to a number of chronic 
respiratory disorders of unknown aetiology that are characterised by persistent slowing of 
airflow during forced expiration. The disorders commonly associated with COPD are asthma, 
chronic bronchitis and emphysema; the common denominator of these disorders is expiratory 
flow obstruction due to narrowing of airways, although the cause is different in each disorder 
(Kaplan, Reis & Atkins, 1985; Lee, Graydon & Ross, 1991). The chronicity of the condition 
may result in incapacitation of the patient physically, psychologically, and socially (Lee et a l, 
1991), causing shortness of breath, (dyspnea), cough, and progressive disability (Agle & Baum, 
1977).
Asthma is the most extensively explored respiratory disorder by psychologists. Only very 
recently have chronic bronchitis, emphysema, and other disorders, been studied in more detail, 
and as such, it is a largely unexplored field for health psychologists.
L l J-uJL Asthma
'Asthma is a disease characterised by an increased responsiveness of the airways to 
various stimuli and manifested by slowing of forced expiration which changes m 
severity either spontaneously or as a result of tiierapy* (American TTioracic Society,
1962; cited in Kaptein et al, 1988).
This description highlights two of the four characteristics of asthma - the hyper-reactivity of the 
airways and the reversibility of the disorder. Three mechanisms (Kossack, 1986; cited in Creer 
& Wigal, 1989) that have been proposed to account for asthma are:
1. Allergens in the environment causing bronchospasm
2. Nonspecific irritants that stimulate nerve receptors in the respiratory tract.
3. Inflections that cause inflammation and swelling of the mucOsa, releasing 
excessive mucus and blocking the bronchial tube (Emmelkamp & van Oppen,
1993).
Reversibility of asthma is particularly important, distinguishing it from other respiratory 
conditions such as emphysema. While many patients show complete reversibility of their 
symptoms, others do not, even with intensive therapy. Frequency of asthmatic episodes may be 
intermittent, varying from patient to patient, and for each patient, from time to time. Severity of 
individual attacks, is also variable. Asthmatic episodes can range from a mild wheeze to fatal 
occlusion of the airways. There is no standard way of classifying a patient as having mild, 
moderate, or severe asthma, despite the fact that these terms are used frequently throughout the 
literature (Creer & Wigal, 1989).
1.1.1. 2 Chrome Bronchitis - This condition is associated with prolonged exposure to non­
specific bronchial irritants, primarily smoking, and is accompanied by the hypersecretion of 
mucus in the airways. In many studies, the production of sputum or presence of a cough on most 
days for at least three months of the year has frequently been adopted as a criterion for diagnosis. 
The predominant result of excess mucus production is reduced airflow; this is Characterised by 
couglmg, wheezing, and dyspnea (shortness of breath). These symptoms are similar to those 
displayed by patients with chronic asthma, and there are sometimes mistakes in diagnosis (Creer 
& Wigal, 1989; Kaplan et a l, 1985).
1.1.1.3 Emphysema - This is defined by the American Thoracic Society (1962; cited in Kaptein 
e;t al, 1988) as an ‘abnormal enlargement of the air spaces distal to the terminal non-respiratory 
bronchiole, accompanied by destructive changes of the alveolar walls’. It is at the alveoli that 
oxygen enters the bloodstream, and carbon dioxide is collected to exhale from the lungs. As 
alveolar walls break down, individual alveoli merge, and the lung gradually loses its elasticity. 
Air becomes trapped in the damaged areas and the lungs become inflated and enlarged (Kaplan 
et a l, 1985). The permanent and abnormal enlargement of the alveoli also lessens the amount of 
lung surface available for oxygen uptake fi-om inhaled air. As in chronic bronchitis, symptoms 
include coughing, dyspnea and wheezing.
1.1.2 Epidemiology
Epidemiological data indicate that the incidence and prevalence of COPD, and asthma in 
particular, varies considerably in different parts of the world, with rates of less than 1% in 
Gambia and Japan, and between 5% and 8% in the Netherlands, Great Britain and the USA 
(Kaptein et a l, 1988). In Australia, 20% of children and 10% of adults have asthma at any one
time - a rate more than twice as high as those reported in the USA and Europe (Bauman, 1993). 
Indications are that both prevalence and mortality rates for COPD are rising (Brooks, Richards, 
Bailey, Martin, Windsor, & Soong, 1989; Buist, 1989).
The economic, psychological, social and medical consequences of COPD can be severe (Janson- 
Bjerklie, Ferketich & Benner, 1993). In the Netherlands, COPD is third on the list of mortality 
causes and the first reason for absence from work in adults (Kaptein et a l, 1988). The economic 
costs are therefore quite considerable, and its incidence is certain to rise in the coming decades, 
primarily as a result of tobacco smoking. In 1986, COPD-related deaths in the USA represented 
3.5% of all deaths in the country. In the UK, asthma-related deaths increased by over 20% in the 
5 years between 1980 and 1985 (Burney, 1986).
In addition to the physical symptomatology characteristic of COPD, it has long been recognised 
that a number of psychological factors are also associated with chronic respiratory diseases.
1.1.3 Psychological Factors Associated with COPD - COPD patients have been reported by a 
number of authors to consistently show higher than average levels of anxict)', depression, and 
social isolation (e.g. Kaptein et a l, 1988; Maes & Schlosser, 1988; Yellowlees, Alpers, Bowden, 
Bryant, & Ruffin 1987). Patients suffering from asthma fr^uently report pessimism about their 
illness and future, and subgroups of patients have reported a high level of psychological stigma.
Early studies showed that patients with respiratory diseases who suffered from breathlessness 
disproportionate to the degree of physiological impairment, had more psychological symptoms.
including anxiety and depression, than patients whose breathlessness was consonant with the 
results of pulmonary tests (Bums & Howell, 1969). Kinsman, Luparello, O'Banion, & Spector 
(1973) found that 42% of asthmatics frequently rated symptoms o f a panic/fear factor as 
occurring with their asthma attacks. These same symptoms are also fr-equently reported by 
people with bronchitis and emphysema (Kinsman, Fernandez, Schocket, Dirks & Covine, 1983).
A review of the psychological aspects of rehabilitation that were important to patients with 
COPD found that anxiety, depression and bodily preoccupation were common problems (Agle & 
Baum, 1977). The subjective experience of anxiety in patients with COPD was reported to result 
fi-om fear of dyspnea, suffocation, and even death, and that when anxiety was disproportionately 
high, patients may avoid realistic physical activity, contributing to functional incapacitation, and 
impeding successful rehabilitation.
Yellowlees and colleagues (Yellowlees et a l, 1987) assessed, both medically and 
psychiatrically, 50 consecutive patients with chronic airflow obstruction who were admitted to a 
respiratory unit. A high rate of psychiatric morbidity (58%) was detected following stmctured 
interview, with panic and other anxiety disorders (24%) being particularly prevalent. A 
subsequent study with 49 patients with COPD reported a similarly high prevalence of psychiatric 
morbidity (Yellowlees, Haynes, Potts & Ruffin, 1988). Patients in these studies were reported to 
be a greater strain on hospital resources than other, less anxious patients with COPD, with more 
fi-equent admissions, and generally staying in hospital for twice as long.
Another study by Karajgi, Rifkin, Doddi & Colli (1990), found that 18% of 50 consecutive 
COPD patients attending a respiratory outpatient clinic, had a present or past diagnosis of mood 
disorder, a figure consistent with epidemiological studies in the general population. However,
lifetime prevalence figures for anxiety disorders (16%) and panic disorder (8%) were interesting, 
as, although figures for anxiety were comparable to those in the general population, the level for 
panic disorder was 5 times higher than in the general population. Their findings were lower than 
those found by Yellowlees et al (1987) and Yellowlees et al (1988), who included in their study 
a number of people who described having had 'near-death' experiences in the past, possibly 
making them more prone to panic. The higher prevalence of anxiety disorder in the Yellowlees 
et al study (1988) may also be due to the use of the Diagnostic Interview Schedule (Yellowlees 
et al, 1988), which is considered over-inclusive for anxiety disorders. There may also have been 
a selection bias in participant involvement as the studies were carried out in respiratory clinics 
where people had come with specific problems in coping with their respiratory disorders.
More recently, van Peski-Oosterbaan, Sponhoven, Willem van der Does, Willems & Sterk 
(1996) reported that 9% of their sample of 123 patients with asthma had panic disorder - a figure 
higher than in the general population, but comparable to the rate observed in non-asthmatic 
medical populations involved in their study. However, in this study, moderate rates of anxiety 
were not reported, so a conclusion about total rates of anxiety in their sample cannot be made.
Despite the wide range of reported incidence of anxiety and panic described in the literature and 
the associated methodological problems of these studies, it does appear that anxiety disorder and 
panic are present in a significant number of people with COPD, to an extent that this additional 
psychiatric disturbance may inhibit adequate coping and engagement in treatment regimes and 
programmes (Carr et a l, 1994; Kaptein et a l, 1988; Porzelius et a l, 1992). Various models 
have been proposed to explain the development of anxiety and panic in this patient group, and 
these will be discussed briefly below.
812 MODELS TO EXPLAIN HIGH PREVALENCE OF ANXIETY
1.2.1 Learned Experience
Breathing is a basic physiological function, and acute dyspnea is one of the most frightening 
human experiences. In COPD, anxiety disorders and panic are characterised by hyperventilation 
and phobic avoidance of certain situations, such as being outside the home without an inhaler or 
a companion. Fear, hyperventilation, and panic tended to occur in the study by Yellowlees and 
colleagues (Yellowlees et a l, 1987) when patients were alone, enclosed, or had worsening 
airways obstruction. Phobic avoidance of these situations was hypothesised to lead to further 
anxiety and the development of a vicious circle of fear, hyperventilation, panic, and avoidance, 
mediated primarily be anticipatory anxiety. Such behaviour was observed to result in significant 
handicaps, with social and functional restriction, and the authors proposed that asthmatic patients 
may develop phobias for situations in which they have had an attack. A number of studies have 
evaluated the use of systematic desensitization and relaxation focusing on the anticipatory fear of 
attacks, although evidence supporting this approach for anxiety reduction and improved lung 
function is limited (Emmelkamp & van Oppen, 1993).
1.2.2 Biological
One hypothesis is that panic attacks may be secondary to certain physiological changes, as it has 
been noted that episodes of panic can be induced by hyperventilation, or rebreathing 
carbondioxide (Gorman, Askanazi & Liebowitz, 1984). It is possible that this occurs in patients 
with chronic airflow obstruction as they often exhibit acidaemia, which occurs when too much 
carbondioxide is present in the lungs. This biological hypothesis, when combined with the fear 
and learned phobic avoidance of certain situations, could account in part for the common 
features of panic and anxiety in some patients with COPD.
1.23 Dyspnea Fear
The dyspnea-fear theory predicts that patients with panic disorder experience 'fear in direct 
response to severe hyperventilation induced dyspnea in the context of little or no perceived 
control over the cause of dyspnea' (Ley, 1989, pp.549). The high prevalence of anxiety and 
panic symptoms among pulmonary disease patients relative to the general population suggests 
that breathing abnormalities (dyspnea) may play a key role in thé experience of panic attacks and 
panic-fear in this population (Carr, Lehrer & Hochron, 1992; Kellner, Samet & Pathek, 1992). 
In early studies of respiratory disease, changes in observed anxiety as well as depressed mood 
were reported with an increase in dyspnea (Dudley, Verhey, Masuda, Martin, & Holmes, 1969). 
The dyspnea-fear model emphasizes the importance of the frequency or intensity of symptoms 
with which the patient frequently copes, many of which can be life-threatening, stressing the 
realism of the belief that the experience of dyspnea may lead to suffocation or death.
1.2.4 Cognitive model
Phenomenologically, some of the symptoms of panic disorder are very similar to the symptoms 
of respiratory diseases, such as dyspnea and choking (Spinhoven, Ros, Westgeest, & van der 
Does, 1994), and a high degree of avoidance of certain situations where breathing pattern may be 
disrupted or temporarily obstructed (Carr et a l, 1992; Kinsman et a l, 1980; Yellowlees et a l, 
1987). For this reason, some authors have investigated the relationship of anxiety and panic to 
COPD using models from psychiatric practice. Cognitive models of panic propose that panic 
results from misinteipretation of physiological or physical symptoms and sensations (Beck, 
1987; Clark, 1986). An enduring tendency to make catastrophic interpretations of a variety of 
bodily symptoms and sensations intensifies the unpleasant somatic sensations associated with 
fear, which in turn increases catastrophic cognitions, resulting in a vicious cycle. COPD patients
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are a population whose physical condition presents them with chronic, or chronic-episodic 
exposure to those physiological sensations associated with the onset of panic (e.g. shortness of 
breath, palpitations, sweating, numbness or tingling sensations, etc). The cognitive theory of 
panic presented by Clark (1986), would suggest that only patients who also experience 
catastrophic cognitions in addition to the physiological sensations associated with COPD will be 
more susceptible to panic as it is the presence of catastrophic interpretations that is the key 
factor. However, the susceptibility of this group to panic may be heightened as the frequency of 
associated physiological sensations in this group might be a vulnerability factor and, given the 
presence of catastrophic cognitions associated with panic, could result in a higher frequency of 
panic attacks than in the general population (Porzelius et a l, 1992). Support for the cognitive 
theory of panic comes from studies in which catastrophic cognitions were modified to produce 
positive or negative changes in affect in patients' response to hyperventilation (Salkovskis & 
Clark, 1990).
13 INVESTIGATIONS OF MODELS
Studies have tried to explain high levels of anxiety and panic in patients with COPD, by 
differences in pulmonary fimction or in cognitions between asthmatics with panic disorder and 
those without. However, a study by Spinhoven, Onstein, & Sterk, (1995) found no relationship 
between signs of actual airways obstruction and panic symptoms in panic disorder patients 
without asthma, which suggests that other factors, including specific cognitions about the 
consequences of experiencing symptoms may be more relevant in providing an explanation for 
the presence of anxiety in people with and without asthma. Although biological and learned 
experience models have been put forward as a possible explanation for anxiety and panic in
11
patients with respiratory diseases, there has been little investigation of their adequacy, with more 
focus in the literature on the dyspnea-fear theory and cognitive theory.
1.3.1 Dyspnea^earmodel versus cognitive model
Some studies liave been carried out with tlie aim of assessing whether Qie dyspnea-fear tlieoiy 
may explain the presence of anxiety and panic amongst patients with COPD (Carr et a l, 1992; 
Kellner et a l, 1992). In their study with 24 asthmatics and 10 panic disorder patients, Carr et al 
(1992) reported that fear of dyspnea accounted for breathing-related anxiety amongst the astiuna 
patients, and that anxiety and panic symptoms in asthma, but not panic disorder, were mediated 
predominantly by the experience of dyspnea. However, there were several limitations to this 
study, the first being the small sample sizes. Selection biases may have been present, as the 
asthmatic patients who volunteered for the study may have been experiencing more stress and 
anxiety than a typical population of asthmatics, as they were already involved in a relaxation 
group. Most importantly, the study did not directly measure panic-related cognitions, and so the 
relative contribution of these to anxiety and panic could not be assessed.
In a revised study, Carr et al (1995) determined the predictive strength of cognitive variables in 
direct comparison to dyspnea-related variables, with a larger sample of patients with asthma, 
testing Clarks' cognitive model of panic disorder (Clark, 1986) as a model for predicting panic- 
fear in asthma. In this model, the frequency and intensity of symptoms is hypothesised to be 
inadequate for the development of anxiety, in the absence of a tendency to misinterpret or 
catastrophise about symptoms. Regression analysis showed that cognitive variables predicted a 
significant amount of the variance on scales of panic-fear and anxiety, even after controlling for 
asthma variables. In contrast to their earlier findings (Carr et a l, 1992), frequency and severity
12
of asthma symptoms were not associated with generalized panic-fear when cognitive variables 
were controlled for, providing strong evidence that the level of pulmonary impairment is not a 
strong predictor of panic-fcar in the absence of catastrophic or irrational thouglits. Tliey 
concluded that 'measures of catastrophic cognitions are a better predictor of anxiety than is a 
measure of asthma symptomatology’, and suggest that ‘cognitions therefore represent an 
important target in psychological interventions aimed at improving the long-term course of 
asthma' (Carr et a l, 1995).
Porzelius et a l (1992) investigated the relationship of catastrophic cognitions, physical 
symptoms, and panic in a population whose presenting problem was respiratory dysfunction 
(physical symptoms) rather than panic. Their study with 48 COPD patients showed that patients 
who experienced impaired respiratory functioning and shortness of breath were highly likely to 
experience panic. \^%ilc all participants experienced physiological sensations associated with 
panic, only 37% had experienced panic attacks, these patients expressing a significantly higher 
fi-equency of fear-provoking thoughts. In those people who did experience panic, there was a 
strong association between physical sensations and agoraphobic cognitions, while degree of 
respiratory impairment and level of general anxiety or depression was less significant, as in the 
study by Carr and colleagues (Carr et a l, 1995), panickers did not differ firom nonpanickers in 
severity of pulmonary disease or severity of shortness of breath, but were distinguished by more 
frequent agoraphobic cognitions and greater fear of body sensations. This data suggests that 
COPD patients experience panic attacks because the symptoms are interpreted catastrophically, 
and not because of higher generalized anxiety, depression, or more severe pulmonary 
impairment.
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Carr and colleagues (Carr et a l, 1994) investigated psychological vulnerability (anxiety 
sensitivity) to panic related phenomena. Anxiety Sensitivity reflects an individuals’ concerns 
about the consequences of experiencing anxiety related symptoms, and is defined as a 
personality trait increasing an individuals’ eonditionabUity to fear. Asthmatics experience more 
symptoms of dyspnea and hyperventilation than do non-asthmatics, and sometimes these 
symptoms can be associated with life threatening exacerbations; however, not all asthmatics 
experience panic. Thus panic attacks in this population were predicted to depend more on 
concerns about these sensations (anxiety sensitivity) than on the actual severity of the illness 
(objective measures of pulmonary function). They found that the experience of severe and 
frequent panic attacks was significantly more common among both asthmatics and 
nonasthmatics who expressed negative beliefs about somatic sensations (high anxiety 
sensitivity), and that these results were not due to differences in pulmonary function. This 
strongly supports Clark's cognitive model where catastrophic misinterpretations of somatic 
sensations are deemed necessary for development of panic disorder. Analysis of panic-related 
cognitions revealed that asthma alone - a disease characterised by frequent and severe bouts of 
dyspnea, wheezing and hyperventilation - was not associated with elevated fears of bodily 
sensatioiis, or with irrational beliefs about the consequences of anxiety, or with catastrophic 
cognitions. On the other hand, patients with asthma and panic disorder had significantly higher 
ratings on these measures relative to asthmatics withouf panic disorder. So, although the 
incidence of panic disorder is reportedly higher among those with asthma than among the 
general population (e.g. Yellowlees et a l, 1987), this cannot be explained simply by the presence 
of asthma or COPD, or by the degree of pulmonary impairment, and its associated symptoms. 
Rather, the findings concur with Porzelius et a l, (1992) and Carr et a l, (1995) in providing
14
evidence that the occurrence of panic attacks among individuals with COPD is due to 
misinterpretations of bodily sensations, as in the general population.
1.4 CLINICAL CONSEQUENCES OF CATASTROPHIZING
The studies described above emphasise the importance of catastrophic cognitions in relation to 
anxiety in patients with COPD. Studies in other chronic illness population groups (Petrie, Moss- 
Morris & Weinman, 1995; Smith, Follick, Ahem, & Adams, 1986; Smith, Peck, Milano, & 
Ward, 1988) have pointed to the particular role of catastrophic thinking in influencing overall 
disability levels, with severe catastrophization about symptoms of arthritis and lower back pain 
being associated with higher levels of disability and depression. In a study with patients 
suffering from chronic fatigue syndrome, (CFS), Petrie et al (1995) showed that individual 
differences in beliefs and cognitions about CFS influenced disability levels through the limits 
and boundaries sufferers set in their level of functioning. They found that differences in 
catastrophic thinking in their sample could not be explained by differences in length of illness or 
in the level of psychological disturbance in the two groups, concluding that it may not be the 
number or seriousness of the CFS symptoms, but their meaning to catastrophizers that is the 
critical factor in limiting functioning.
A recent review of cognitive processes in chronic pain patients (Smith et a l, 1986) concluded 
that catastrophizing is the most important factor in poor coping with chronic conditions, and is 
strongly related to greater disability. Catastrophizing has both direct and indirect effects on the 
physiological processes that may maintain or even exacerbate a chronic disorder, for example, in 
chronic pain, negative cognitive interpretations can cause direct effects by increasing autonomic 
or nervous system arousal. Indirect effects can occur as a result of reduced physical activity.
15
It is important to bear in mind that cognitive factors have a uniquely significant role in patients 
suffering fi-om chronic compromised respiratory fimctioning. The physiological sensations 
associated witli COPD ait: generally chronic, ullcn progressive, and may trigger more severe 
problems. Catastrophic interpretations of bodily sensations cannot necessarily be termed 
'misinterpretations' since the hyperventilation and panic which can result from these cognitions 
could really produce the health risk suggested by the catastrophic thoughts. It would therefore 
be important in treatment, to carefully assess the nature and extent of cognitions relating to 
COPD symptomatology. Modification of catastrophic cognitions may be important if Üiey are 
shown to cause excessive anxiety to the patient, resulting in an inability to cope adequately and 
appropriately with symptoms. However, a certain amount of anxiety could actually be helpful in 
alerting patients to a potentially life-threatening exacerbation of breathing problems (Kinsman et 
a l, 1983).
1.5 SUMMARY OF RESEARCH AND IMPUCATIONS FOR TfflS STUDY
From the literature discussed above, it is apparent that there is great variation between the 
findings of different researchers. Figures reported for the prevalence of anxiety and panic 
disorders vary from 9% - 37% (Karagji et a l, 1990; Porzelius et a l, 1992; van Peski-Oosterbaan 
et a l, 1996; Yellowlees et a l, 1987). These differences appear to be due to different criteria for 
assessment and diagnosis of anxiety and panic, different methodologies used in studies, and 
possible selection biases amongst patients who took part in each of the studies (Carr et a l, 1995; 
van Peski-Oosterbaan et a l, 1996). Despite these differences, the widespread reporting of higher 
than normal levels of anxiety amongst people with COPD, and asthma in particular (Kinsman et 
al, 1979; Kiiisinaii at u l, 1983), appears to be an accepted factor associated with respiratory 
disorders. The consequences of experiencing clinical levels of anxiety have been demonstrated
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to be detrimental to patients' ability to cope adequately with their respiratory disease, resulting in 
inappropriate over-use of steroid medications, excessive use of as-needed medications, and more 
frequent and longer hospital admissions (Dahlem, Kinsman & Horton, 1977; Dirks, Fross & 
Evans, 1977; Kinsman et a l, 1980). These effects are independent of objectively measured 
pulmonary impairment. Engagement in rehabilitation programmes has been reported to suffer, 
with patients being unable to utilise adequate coping strategies, and high drop-out rates amongst 
this subgroup of COPD sufferers (Kaptein et a l, 1988).
Various models have been explored in an attempt to understand why some patients with chronic 
respiratory conditions may be more susceptible to developing anxiety and panic disorders than 
people without these conditions. The high prevalence of anxiety and panic symptoms among 
pulmonary disease patients relative to the general population suggests that breathing 
abnormalities play a key role in the experience of panic attacks and panic-fear in this population.
To date, the most extensively explored theories are the dyspnea-fear theory (Lee et a l, 1989) 
and the cognitive model of panic (Clark, 1986). Studies have shown that in the absence of 
catastrophic thoughts, dyspnea-fear and severity of symptoms do not adequately explain anxiety 
and panic in patients with COPD (Carr et a l, 1995; Porzelius et a l, 1992; van Peski-Oosterbaan 
et a l, 1996). In the study by Porzelius and colleagues (Porzelius et a/., 1992) patients with 
COPD and panic disorder reported a high frequency of fear-provoking thoughts in contrast to 
COPD patients who did not panic, while there was no difference between the groups in severity 
of pulmonary impairment.
Despite evidence that the presence of catastrophic cognitions appear to be a necessary factor for 
the experience of panic and anxiety in COPD, there are no studies to date that have attempted to
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show the causal role of specific cognitions relating to symptoms of respiratory disease in 
predicting anxiety and panic reactions among pulmonary disease patients. There are also no 
studies which have described tlie precise content and focus of the catastrophic thoughts identified 
as being present through questionnaires such as the Agoraphobic Cognitions Questionnaire 
(Chambless, Caputo, Bright, & Gallagher, 1984). Self-report measures of these cognitions may 
provide a useful insight into these, and hence a firm focus for treatment aimed at modifying the 
content of these thoughts. In studies of panic disorder (Clark, 1986), catastrophic thoughts in 
relation to somatic symptoms of anxiety and panic, focus on the negative consequences of those 
symptoms and include thoughts of suffocation, loss of control and dying. Clinical experience 
suggests that maybe the precise content of thoughts in COPD may be more specifically related to 
respiratory disease. If catastrophic thoughts are identified amongst a group of patients with 
COPD, then it may be reasonable to predict that these people would also have significant levels 
of both illness-focused anxiety and general anxiety.
One of the aims of this study is to ascertain the presence and severity of catastrophic thoughts 
about the consequences of experiencing symptoms of respiratory disease amongst a group of 
outpatients with COPD, and whether more severe catastrophic thoughts are associated with 
higher levels of anxiety. The precise content and focus of thoughts in relation to these 
symptoms, will also be determined, and the relationship of catastrophic thoughts to anxiety will 
be explored. The relative contribution of variables in prediction of anxiety, such as illness 
severity and duration of COPD (Carr et al, 1995; Porzelius et a l, 1992), and age (Maes & 
Schlosser, 1988) will be explored. Another important variable which will be investigated in 
addition to those outlined above is the potential contribution of social support and its relationship 
to anxiety. Perception of social support has been shown to bear a strong negative relationship to
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anxiety and depression, and to have important implications for health status and mortality (Sandler 
and Barrera, 1984; Sarason, Shearin, Pierce & Sarason, 1987).
The first aim of this study is to develop a questionnaire that will be appropriate for use in
ascertaining the presence, content and severity of catastrophic thoughts in relation to symptoms 
associated with COPD. Once this questionnaire has been developed, and its’ psychometric 
properties assessed, the following hypotheses will be tested:
Hypothesis 1: A high prevalence of clinically significant anxiety will be found in a sample of 
COPD patients.
Hypothesis 2 : The presence of more severe catastrophic thoughts will be related to higher levels 
of (a) generalised anxiety (HADS anxiety) and (b) specific anxiety ratings.
Hypothesis 3: In situations that are perceived as being more threatening (‘unsafe’), participants 
are more likely to, (a) have more severe catastrophic thoughts; and (b) report higher levels of
anxiety in response to symptoms, than in situations perceived as less threatening.
Hypothesis 4: Severity of catastrophic thoughts (open-ended responses) will predict more of the 
variance in anxiety than other variables associated with anxiety, including disease severity, 
duration of COPD, age. and satisfaction with social support.
Section 2
METHOD
s
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As no questionnaire existed which specifically assessed cognitions related to COPD 
symptomatology, one of the aims of the study was to develop a questionnaire which would do 
this. Information was gathered through interview with 6 COPD patients, and details of this, and 
the development of the questionnaire content and format is described below, in addition to 
information on the main study. Assessment of the reliability and validity of the resulting 
questionnaire is described in the Results section.
2.1 PARTICIPANTS
2.1.1. Initial Investigations: People attending the Pulmonary Rehabilitation Programme at the 
hospital Wiere the study was based, were approached by letter (Appendix 1) which 
included a consent form (Appendix 11), and a prepaid envelope for the return of 
completed consent fonns.
2.1.2. Main Study: Potential participants were selected from the following groups: (1) people 
who had attended past Pulmonary Rehabilitation Programmes, (2) people who attended 
the Chest Clinic at the hospital where the study was based, and (3) people who attended a 
Respiratory Clinic at a General Practice in the local town. All potential participants were 
invited to take part in the study via an information letter (Appendix 111), which included a 
consent letter (as above), and a prepaid envelope for its return. Potential participants who 
did not reply to the original letter within 4 weeks were sent a reminder letter (Appendix 
IV).
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2.13. Both Studies: Criteria for inclusion for both studies was a diagnosis of COPD (including 
asthma, bronchitis and/or emphysema), and participants had to be aged over 18 years. Potential 
participants were excluded if they had other significant physical illness, or were known to have 
significant mental health problems. This was ascertained by the Consultant Chest Physician and 
the General Practitioner involved, who were familiar with their patients’ medical histories.
2.2 DESIGN
2.2.1 Initial investigations were completed as a structured interview
2.2.2 Main Study was a within subjects design, usmg three standardized questionnaires, one new 
measure designed following initial investigations, and a background information sheet.
23 MEASURES
2.3.1. Development of the questionnaire through initial interviews:
Table 1 gives demographic data for the six participants who took part in the initial investigations. 
Table 1: Demographic data for participants who took part in initial interviews
Number Mean age - 
years 
(SD)“
Mean duration 
of COPD - 
years (SD)
Female 4 65.0 (8.2) 6.0 (3.7)
Male 2 58.0 (7.0) 6.0 (5.0)
Total 6 62.7 (8.5) 5.8 (4.0)
Standard Deviation
The age-range of the participants was 51-79 years, with a mean of 62.7 years (SD=8.5) for the 
whole sample. Of the six participants, four (66%) were female and two (33%) were male. All 
participants in the pilot study had a diagnosis of COPD, and within this diagnosis, two had 
asthma and four had emphysema. The duration of illness for the group ranged between one and
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11 years (mean,5.8 years; sd, 3.98). All had participated in a Pulmonary Rehabilitation group 
over the year preceding the study.
2.3.2. Initial gathering of information. This involved completion of a structured interview 
designed by the author (Appendix V), to assess:
(i) Symptoms commonly experienced in relation to COPD (based on the Asthma 
Symptom Checkhst (Kinsman et al, 1973), and the Bronchitis and Emphysema 
Symptom Checkhst (Kinsman e/a/., 1983));
(ii) Thoughts relating to the experience of those symptoms;
(iii) Situations and activities avoided in order to avoid experiencing those symptoms.
In addition, a list of 14 different situations discussed at initial interview, was given to 14 
healthcare professionals with asthma, who rated them on a scale of 1-4 for their perceived safety 
in the event of experiencing breathing difficulties related to their asthma, with 1 being most 'safe', 
and 4 being most 'unsafe'.
The information from this initial study was used in development of the 'Interpretation of 
Breathing Problems Questionnaire' used in the main study (see below).
2.3.3. Main Study:
2.3.3.1 Interpretation of Breathing Problems Questionnaire (IBPQ): This 14 item questionnaire 
(Appendix VI) consisted of 14 items, comprising seven symptoms commonly associated with 
COPD, each presented in two different situations. Initial interviews suggested that the type of 
situation in which symptoms were experienced may be important. Hence, following statistical 
testing on the ratings of safety, seven ‘safe’ and seven ‘unsafe’ situations were included in the
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questionnaire items to explore the influence of situation on catastrophic thoughts and anxiety. 
Presentation of the items within the questionnaire was randomised. For each item, there was a 
brief description of a symptom experienced in one of 14 situations, (for example, 'You are on a 
long walk alone, and you begin to feel short of breath') which was then followed by three open- 
ended questions; 'What would you do in this situation?', 'What thoughts go through your mind?', 
and 'What is the worst thing you think may happen to you?'. These questions were designed to 
elicit any associated catastrophic cognitions. Participants were asked to write the first thing that 
came into their mind in response to these questions. There then followed three visual rating 
scales ifrom 1-10, with instructions to rate (in relation to the information presented in each item)
(i) their anxiety (where 1 is no anxiety and 10 is maximum anxiety), (ii) their behef that they will 
become ill (where 1 is no illness and 10 is total belief that they will become ill), and (iii) their 
belief that they will die, (where 1 corresponds to 'definitely won't die' and 10 corrsponds with 
'definately will die'). Finally, participants are asked to respond yes or no to whether they would 
avoid the situation if they experienced the symptom presented in each item.
The questionnaire was prefaced with an information sheet, explaining the rationale, and how to 
complete items. It also stated that if participants would normally avoid a situation presented, they 
should still answer questions, by imagining their responses as if they were in the situation.
Open-ended responses were judged by two independent judges (see Appendix XVII for 
categories), and information on reliability and vahdity of the questionnaire is presented in the 
results section.
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2.3.3.2 Hospital Anxiety and Depression Scale fHADS): (Zigmond and Snaith, 1983). The 
HADS is a 14 item self-report scale developed expressly to measure anxiety and depression 
amongst medical outpatients (Appendix VII). Total scores for each subscale are obtained by 
adding together responses to individual items, with the range of possible scores for each subscale 
of 0-21. Results are interpreted according to scoring bands, which can be found in Appendix 
VIII. This study used only the anxiety scale, (seven items) which measures general state anxiety 
experienced over the week prior to completion of the measure. The instrument was chosen as it 
has good psychometric properties (rehability: Cronbachs alpha=0.93) for medical patients aged 
16-65 years (Zigmond and Snaith, 1983), and 65 years and above (Chaturvedi, Chandra, 
Channabasavanna & Beena, 1994; Johnson, Burvill, Anderson, & Jamrozik, 1995). The HADS 
does not include somatic symptoms of anxiety and hence is unlikely to be confounded by 
participants physical symptoms associated with COPD.
23  J.-3 St Georges Respiratory Questionnaire (SGRO): The SGRQ is a standardized seU-
completed questionnaire for measuring impaired health and perceived well-being (quality of life) 
in airways disease (Jones, Quirk & Baveystock, 1991) (Appendix IX). The original questionnaire 
contains 76 items, contributing to three component scores: symptoms, activity, and impact on 
daily life. For this study, only the ‘symptoms score, containing nine items answered using a 
rating scale, which assess frequency and severity of symptoms associated with COPD, was used 
as a measure of illness severity. % Responses are weighted, and together provide a percentage 
figure where higher percentage figures have been shown in studies to correlate with more severe 
physiological impairment related to respiratory disease (Jones, Quirk, Baveystock, & Littlejohns, 
1992). The questionnaire has been demonstrated to be a valid measure of impaired health in
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diseases of chronic airflow limitation, that is repeatable (alpha=0.91) and sensitive (Jones et al, 
1992).
23.1.4 ShojçŒorm Social Support Questionnaire (SSQ6): (Sarason et a/., 1987). The SSQ6 
(Appendix X) is a six item version of the original 27 item SSQ (Sarason, Levine, Basham, & 
Sarason, 1983). It yields one quasi-structural measure (SSQ6-N; number of supports), and one 
global functional measure (SSQ6-S; satisfaction with support). It is a self-report measure, taking 
under 10 minutes to complete. For each of the six questions, participants are asked to Hst ail the 
individuals known to them who provide the particular type of support described in each question. 
Respondents then have to rate, on a six-point scale, their level of satisfaction with this type of 
support. For this study, only the SSQ6-S measure was used in analysis, yielding a mean 
satisfaction score across all six items. The SSQ6 has high internal consistency (alpha=0.93), and 
good test-retest reliability. Validity is also reported to be good with superior sensitivity to other 
scales in a comparison study (Sarason et al, 1987).
2.3.3.5 Background Information: Consisting of nine items, the Background Information Sheet 
(Appendix XI) included basic demographic data (age, date of birth, sex), specific diagnosis, 
duration of illness, medication use, number of hospital stays relating to COPD, (in total, and 
within the last year), and average duration of m y  periods spent in hospital. The information sheet 
was designed by the author, based on a similar one used in another study with people with 
breathing disorders, which was designed by a Clinical Psychologist in conjunction with an 
experienced Chest Physician (Schembri-Wismayer, 1995; personal communication). No formal 
tests of its reliability and validity were carried out.
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2.4 PROCEDURE
Regional Ethics Committee approval was sought and received initially to complete the pilot study 
for the development of the IBPQ (Appendices XII and XIII). Permission was also given by the 
ethics committee to approach potential participants for the main study, and to use the HADS.' 
Following completion of the initial investigations, and subsequent development of the IBPQ, the 
questionnaire was given approval, and later applications gained approval to use the SGRQ, and 
the SSQ6 (Aee Appendices XTV and XV).
2.4.1 Initial Investigation: All people who returned consent forms agreeing to take part in the 
study were contacted by telephone, and appointments made to interview them in their homes 
(although there was an option of being interviewed at the hospital, no-one chose it). At interview, 
the rationale was again explained, and participants completed the structured interview with the 
author present to help with any difficulties or questions that came up. Interviews lasted around 60 
illinutes.
2.4.2 Main Study: People who returned consent forms and who agreed to take part, in response 
to the original information letter or reminder, were contacted by telephone, and an appointment 
made to see them at home (again, no-one chose to be interviewed at hospital). Those people who 
returned the consent forms with requests for more information were also contacted by telephone, 
and additional information given. They were then given the option to take part or not. People 
who returned the form and chose not to take part, and those who did not respond to the reminder 
letter, were not contacted again by the author.
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The author was present at all interviews, which lasted between 45 and 90 minutes. An 
explanation of the rationale was given, and there was time for participants to ask any questions 
about the study during the interview. Each of the 5 measures was presented with verbal and 
written instructions, and participants either completed these themselves, or, for those who had 
difficulty with writing, verbal responses were given to each question, and forms were completed 
by the author. 18 participants also agreed to complete the IBPQ a second time, 4-6 weeks after 
their initial interview. Retests were completed independently, sent by post with a covering letter 
(Appendix XVI) and a prepaid envelope. A contact number was included in the letter to ensure 
any questions they may regarding completion could be answered.
Section 3
RESULTS
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3JSESIJLTS
3.1 OVERVIEW OF RESULTS SECTION
Demonstration of reliability and validity factors associated with the development of the IBPQ 
was completed concurrently with investigation of the core hypotheses, due to restrictions in 
time for completion of the project. Hence, the same participants were involved in both stages of 
the project. Following presentation of details of sample characteristics and scores on self-report 
questionnaires, investigations of the rehability and validity of the IBPQ will be presented, with 
examples of the types of open-ended responses ehcited by the questionnaire. There will then be 
details of the statistical investigations of the four core hypotheses.
3.1.1. Response Rates
Details of response rates are presented in Table 2.
Table 2. Table of responses to letters inviting potential participants to take part
Total number of 
letters sent (%)
Number of 
responses - agree to 
participate (% of 
total letters sent)
Number of 
responses - decline 
to partake (% of 
total letters sent)
Number of hio’ 
responses (% of 
total letters sent)
Females
Males
Total
32 (49.2)
33 (50.8)
65 (100)
19 (29.2) 
18 (27.7)
37 (56.9)
9 (13.8) 
7 (10.8)
16 (24.6)
4 (6.2) 
8(12.3)
12(18.5)
A total of 65 letters were sent to potential participants inviting them to take part in the study, 
ehciting responses from 53 people (82% response rate) of whom 16 people (25% of the total 
sample) declined to participate. Twelve of the people approached (19%) did not respond, 
despite reminder letters being sent. Of the 37 people who chose to take part, 19 were female, 
and 18 were male.
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3.1.2 Demographic Data for the sample is presented in Table 3. 
Table 3. Demographic data for participants in main study
Number Mean age 
in years 
(SD)'
Mean 
duration of 
illness in 
years (SD)
Mean number 
of visits to 
hospital 
(SD)
Medication - 
Number of 
participants on: 
Inh*’ Ste" Oj'*
Individual diagnoses 
(within COPD®)
Asthma Emph/Bron® Other^
Females 19 52.3(21.8) 9.8(17.8) 1.2 (1.8) 5 11 3 11 8 0
Males 18 66.9 (8.1) 12.2(15.9) 0.9 (2.0) 3 12 3 5 12 1
Total
à-—j
37
• b;;.- ■
59.4(17.5) 11.0(16.7) 1.1 (1.9) 8 23 6 16 20 1
‘‘Oxygen for a minimum of 16 hours per day, in addition to inhalers and steroid medication; "Emphysema &/or bronchitis; 
‘ÎForms o f COPD other than asthma, emphysema and bronchitis; “Chronic Obstructive Pulmonary Disease.
The mean age of participants was 59.4 years (SD=17.5; median=64 years; range=18-80 years). 
The mean age of females was 52.3 years (SD=21.1; median=59 years; range= 18-80 years), and 
for males was 66.9 years (SD=8.1; median=67.5years; range=51-78 years). The mean duration 
of illness for the whole sample was 11 years (SD=16.7; median=7 years; range=l-80 years), and 
thé mean number of hospital visits in the last year was 1.1 (SD=1.9; range=0-8 visits). While 
the whole sample used basic inhaler medication, 29 people (78%) took steroids in addition, and 
of these, 6 people (16%) used oxygen for a minimum of 16 hours per day as well. Each 
participant fulfilled the criteria for COPD, and within this diagnostic category, 16 people (43%), 
11 of them females, had asthma, 20 (54%) had bronchitis or emphysema, and one person (3%) 
had lung disease related to asbestos exposure.
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3.1.3 Self Report Questionnaires The data from the self-report questionnaires is presented in 
Table 4.
Table 4: Mean scores on HADS, SGRQ and SSSQ6.
Mean
HADS®
(SD)'
Number of
scores above 
cut-off (%)
Mean score 
on 
SGRQ** 
(SD)
Mean score 
on 
SSQ6* 
(SD)
Female (n=19) 
Male (n=i8)
Total (n=37)
8.5 (3.7)
7.1 (4.2)
7.8 (4.0)
0_* A.-
14 (73.7) 
7 (38.9)
21 (56.8)
71.1 (21.2) 
71.8(19.4)
71.4(20.0)
1 ^
4.7 (1.4) 
5.0 (1.2)
4.8 (1.3)
Zigmond, 1994); "Hospital Anxiety and Depression Scale; S t George’s Respiratory 
Questionnaire; "Short Form Social Support Questionnaire-6
Hospital Anxiety and Depression Scale (HADS) scores for the whole sample had a mean of 7.8 
(SD=4.0; range-0-15). Of these, 21 participants (57%) scored above 7, the cut-off for 
borderline anxiety (Snaith and Zigmond, 1994), this figure comprising 13 female participants 
(67%).
St. George’s Respiratory Questionnaire (SGRQ) scores for the whole sample had a mean of
71.4 (SD=20.0; range= 15-98).
Short-Form Social Support Questionnaire-6 (SS06) scores for the whole sample had a mean of 
4.8 (SD=1.3; range=2-6).
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33 THE INTERPRETATION OF BREATHING PROBLEMS QUESTIONNAIRE (IBPQ)
The ‘Interpretation of Breathing Problems Questionniare’ (IBPQ) was designed to eUcit a range 
of cognitions relating to symptoms of COPD. Before the psychometric properties of the 
questionnaire are described, a brief descriptive summary of the range of cognitions elicited will 
be presented, to give the reader an example of the type of responses that were given to open- 
ended questions.
Open-ended responses were categorised into non-catastrophic, moderately catastrophic, and 
severely catastrophic thoughts (see Appendix XVll for defining categories). In total, 302 
(58%) of the 518 responses were classified as non-catastrophic, 132 (25%) were classified as 
moderately catastrophic, and 83 (16%) as severely catastrophic (one response was missing). 
Table 5 gives four examples of each type of response, while a more inclusive table of the range 
of responses in each category is given in Appendix XVlll.
Table 5: Examples of types of open-ended responses according to category of severity
Category of response Examples of responses
Non-catastrophic
‘I’m OK because the Dr. is here, so even if 1 get worse I’ll be 
OK’
‘I’ll cope because my husband is always here {at home) with 
me’
‘Embarrased {at wheezing in company), but I’ll take my 
ventolin and I’ll be fine’
‘I’ll be alright after a rest’
Moderately
catastrophic
‘I’m going to have a problem breathing’
‘1 won’t be able to catch my breath’
‘1 must slow down and take my ventolin or it {my breathing 
will get worse’
‘I’ll get dizzy and breathless’
Severely catastrophic
‘1 must get out {of the smokeypub) - very anxious - I’ll 
collapse’
‘I’ll stop breathing and get brain damage’
‘1 haven’t got much time before 1 collapse’
‘It {wheezing) will get worse -1 won’t be able to breathe, and 
1 wouldn’t have any oxygen with me’
/ 1
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Establishment of the psychometric properties of Interpretation of Breathing Problems 
Questionnaire (IBPQ)
3.2.1 Safety ratings for 14 different situations: Is there a significant difference between 
ratings of safety, given the seven 'safe' and seven 'unsafe' situations used in the IBPQ?:
Twenty people (See Method, Section 2.3.2 (iii)) were asked to rate 14 different situations that 
had been described as 'more safe' and 'less safe' during the initial interviews, on an ordinal scale 
of 1 (safe) to 4 (unsafe). Table 6 summarises the responses.
Table 6: Ratings o f  how safe or unsafe 14 different situations were.
Situations Mean (SD)' Friedmans 2-way Anova
d.f.*’ c'® P
Safe 1.29 (0.51) 6 8.4 0.21
Unsafe' 3.04 (0.84) 6 11.9 0.07
All 14 2.18 (1.14) 13 171.9 0.0001
standard deviation; degrees of freedom; Chi-squared
The mean score for 'safe' situational variables was 1.29 (SD=0.51), and for 'unsafe' was 3.04 
(SD=0.84). Ratings were made on an ordinal scale, and a Kolgomorov-Smimoff Goodness of 
Fit Test indicated that the data not normally distributed. For these reasons, a Friedmans 
Two-Way Analysis of Variance was used in analysis of the data. This revealed the presence of 
a significant difference (Chi-Square=171.9; d.f.=13; /?<.0001) in ratings given to the 14 
situations. When the 14 variables were split into the seven 'safe' situations and the seven 
'unsafe' situations, two further Friedmans Two-Way Analyses of Variance found no significant 
differences between ratings given to the 14 situations, (safe: Chi-Square=8.4; d.f.,6; non­
significant; unsafe: Chi-Square=l 1.9; d.f.=6; non-significant). .
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3 3 3  Inter-rater reliability for open-ended responses (cognitions):
Open-ended responses to each of the 14 items in the IBPQ provided a range of cognitions from 
each of the 37 participants. All responses (518), were rated by two independent judges, who 
allocated them into one of three categories: non-catastrophic, moderately catastrophic, and 
severely catastrophic. Rating categories are defined in Appendix XVII. A summary of the 
correlation of these ratings is presented in Table 7.
Table 7: Summary of correlation of ratings by judges 1 and 2
Judge 2
Non-cat.' Mod. cat.® Sev.cat®
Non-cat. 285 17 0
Judge 1 Mod. cat 7 100 25
Sev.cat 1 2 80
Note: Figures in bold represent responses rated same by both judges; 
"non-catastrophic rating; '’moderately catastrophic rating;
"severely catastrophic rating
Four hundred and sixty-five (90%) of the 518 responses were rated the same by both judges, 
with a total of 285 non catastrophic, 100 moderately catastrophic, and 80 severely catastrophic 
thought ratings. There was one missing response due to one participant being unable to answer 
one question. Judge 2 rated 42 responses in one category as more catastrophic than they were 
rated by judge 1, and only eight responses were rated more catastrophic by judge 1. Overall 
reliability was calculated using Cohens Kappa, ehciting a value of 0.83 (standard error=.02). 
This indicated a ‘substantial’ to ‘almost perfect’ agreement between judges, (95% confidence 
interval, (0.79, 0.870)) (Landis and Koch, 1977), One participant (number 34) responded to 
each of the 14 open-ended questions with exactly the same response, (‘I'd have difficulty 
breathing'), which was rated by both judges as moderately catastrophic. The Kappa value was
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therefore recalculated without this data, as a series of identical responses might skew results, 
giving a higher inter-rater reliability value than would be obtained if there were a variety of 
responses from each participant. The recalculated Cohens K ^ p a  value was 0.82 (Standard 
error=.23), again, indicating substantial agreement (95% confidence interval (0.78,0.86)).
3.23 Test-Retest Reliability: Eighteen participants completed the IBPQ a second time, four 
to six weeks after the original assessment session. Test-Retest Reliability was calculated for 
each of the 14 questions, for open-ended responses, ratings of anxiety, ratings of belief in 
becoming ill, and ratings of belief in dying.
Open-ended responses: Correlation coefficients were calculated for each of the 14 questions, 
and the percentage of responses in die same category at die second testing was also calculated. 
A Kendall-Tau test was chosen as a Kolgomorov-Smimoff Goodness of Fit Test indicated that 
the distribution of scores of catastrophic thoughts was not normal, and the range of categories 
was only small (1-3). A summary of correlation coefficients for open-ended responses is 
presented in Table 8.
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Table 8: Test-retest reliability of open-ended responses - Correlation coefficients, significance, 
and number of items scored identically at first and second testing.
Correlation
Coefficient
Number of participants 
rating item same at 2nd 
testing (%)
( n=18)
Safe Situations
Friends house - chest tight .66** 16 (89)
Stairs/home - hard to breathe .65** 14 (78)
Hospital - tired/exhausted .47"^ 14 (78)
With Physio - chest congested .85**** 17 (94)
Home with friend - wheeze 85**** 16 (89)
GP surgery - cough heavily .79*** 14 (78)
Garden/friend - short of breath .55* 14 (78)
Unsafe Situations
Smokey Pub - chest tight .78**** 13 (72)
Stairs at shop - hard to breathe .70** 12 (67)
Crowd/town - tired/exhausted 82**** 14 (78)
Drive-m/way - chest congested 72*** 12 (67)
Crowded bus - wheeze .87**** ■ 15 (83)
Supermarket - cough heavily .84**** 13 (72)
Long walk - short of breath 1.00**** 18 (100)
*/7<.05; **p<.01; ***p<.001; ****/?<.0001;**^on-significant
Correlation coefficients ranged fi-om .47 - 1.00, with all correlations being significant at a level 
of /?<.01 except for two items (In the garden with a jfriend - short of breath; At hospital - tired 
and exhausted), which were significant at p<.05, and non-significant at /?=.051, respectively. 
For the whole group, the mean percentage of items rated the same on test-retest for each 
question was 80% (SD=9.46; range=67 -100%).
Ratings o f  anxiety, belief in becoming ill, and belief in dying: Due to the small number of 
participants who took part in the retest condition (n=l 8), it was decided to use a non-parametric 
statistical test to assess for significant differences between ratings over time, despite the 
indication firom a Kolgomorov-Smimoff Goodness of Fit test that there was no evidence to 
suggest that the data was not normally distributed. A Wilcoxon Matched Pairs Signed-Ranks
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test was used to analyse differences in test-retest ratings of anxiety; belief in becoming ill; and 
belief in dying; for each of the 14 questions in the IBPQ. A table of results for individual items 
on the questionnaire can be found in Appendix XIX. Table 9 summarises these results.
Table 9: Test-retest rehability data for anxiety scores, behef in becoming iU, and behef in 
dying, in the seven 'safe' and seven 'unsafe' situations.
Range of z 
scores
Range of 
significance 
levels
Number of items 
with significant 
differences at 
retest (%)
7 *safe* items
Anxiety ratings -2.58--0.10 0.01-0.92 1 (14)
Behef in becoming ill -2.19- 0.00 0.03 -1.00 1 (14)
Behef in dying -1.35- 0.00 0.18-1.00 0 (0)
7 * unsafe’ items
Anxiety ratings -2.10--0.35 0.04 - 0.72 2 (29)
Behef in becoming ill -1.78--0.18 0.08 - 0.86 0 (0)
Behef in dying -1.48 —0.18. 0.14-0.86 0 (0)
Differences in anxiety ratings for all but three questions were non-significant. The three 
questions for which the Wilcoxons analysis indicated significant differences in test-retest 
ratings were: Going up the stairs in a shopping centre and finding it hard to breathe; Being in a 
crowd in town and becoming tired and exhausted; Being round a fiiends house and your chest 
becoming tight. Z-scores for these responses were -2.10, -2.04 and -2.58 respectively, and all 
were significant atp<.05.
Belief in becoming ill ratings revealed no significant differences between test and retest for all 
but one item (You are at the hospital and begin to feel tired and exhausted; z = -2.19; jcK.05), 
and analysis o f  belief in dying ratings revealed no significant differences between responses on 
the initial and retest situations.
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3.2.4 Internal Consistency: Cronbachs Alpha was calculated to determine the homogeneity of 
the 14 items used to measure severity of catastrophic thoughts on the IBPQ. A summary of 
Alpha values (‘if each item were deleted from the questionnaire’) is presented in Table 10.
Table 10: Internal Consistency - Alpha values for IBPQ if each item were deleted from the 
questionnaire.
Cronbach ’s alpha for whole scale = .90
Alpha if item 
deleted
*Safe’Situations
Friends house - chest tight .90
Stairs/home - hard to breathe .90
Hospital - tired/exhausted .91
With Physio. - chest congested .90
Home with friend - wheeze .89
GP surgery - cough heavily .90
Garden/friend - short of breath .90
*Unsafe* Situations
Smokey Pub - chest tight .91
Stairs at shop - hard to breathe .89
Crowd/town - tired/exhausted .89
Drive-m/way  -  chest congested .89
Crowded bus - wheeze .89
Supermarket - cough heavily .90
Long walk - short of breath .89
The results of the analysis show that internal consistency of the scale is extremely high with an 
overall Cronbach’s alpha value of .90. When items were analysed individually, there were none 
that would have significantly altered the overall alpha value if removed.
3.2.5 Construct Validity: Anxiety ratings for each of the 14 questions were correlated with 
the HADS score tor each participant. However, the responses of one participant (number 34) 
were thought likely to skew correlation coefficients as a result of responses being identical, with 
consistently high ratings of anxiety, belief in becoming ill, and behef in dying, particularly for
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the 'safe' situations. This is indicated by Figures 1-3 in Appendix XX, which suggest that this 
participants' scores are significant outliers when compared to the scores obtained on the 
measures by the rest of the sample.
For this reason, correlations were carried out first for all 37 participants, and then recalculated 
for 36 participants, without the data from this participant. A Pearsons correlation was used as a 
Kolgomorov-Smimoff Goodness of Fit Test indicated that there was no evidence to suggest that 
HADS scores and anxiety ratings were not both normally distributed. A summary of the results 
of these analyses is presented in Table 11, and a table of individual correlations and significance 
levels can be found in Appendix XXI.
Table 11: Correlations of anxiety ratings for each question, with individual HADS scores, for 
(i) all 37 participants, and (ii) without outliers scores.
Range of 
Correlation 
Coefficients
Mean
correlation
(SD)'
Number of 
/7<0.01 
values (%)
Number of 
non-sig. 
values (%)
(i)AIl
participants
(n=37)
HADS® 
score 
correlated 
with: -
- anxiety ratings - 
safe situations
- anxiety ratings- 
unsafe situations
.17-.39  
.16-.52
.26 (.07) 
.41 (.11)
1 (14) 
6 (86)
3 (43) 
1 (14)
(ii) Excluding
outlier
(n=36)
HADS 
score 
correlated 
with: -
- anxiety ratings - 
safe situations
- anxiety ratings- 
unsafe situations
.32 - .64 
.22 - .62
.44 (.10) 
.50 (.12)
5 (71)
6 (86)
0 (0) 
1 (14)
"standard deviation, "Hospital Anxiety and Depression Scale
(Ï) Coirelations with data from all 37 participants: Correlation coefficients ranged from .16 to 
.52 for the 14 items. For 'safe' situation anxiety ratings, four items were significantly correlated 
with HADS scores at ap<.05 level, with non-significantp-values for the other 3 items of .11- 
.16. A significance level ofp<.Ol was obtained for all 'unsafe' situation anxiety ratings except
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for one: Driving down a motorway and your chest begins to become congested, which was non­
significant (p<. 18).
(ii) Correlations with data excluding the outlier: When the outlying scores were excluded from 
the analysis, correlation coefficients ranged from .22 to .64 for all 14 anxiety ratings with the 
HADS scores. Significance levels were all at /?<.05 for all items, again with the exception of 
the item outlined in the previous analysis, which remained non-significant. In the 'safe' 
situations, when data for participant 34 was omitted, five anxiety ratings became significantly 
correlated with HADS scores at the/7<.01 level, and 2 at/?<.05.
As a further measure of construct vahdity, the severity of catastrophization in responses to 
open-ended questions was correlated with ratings of anxiety on the IBPQ. The results of these 
correlations are shown in Table 12. A table of individual correlations for each item is 
presented in Appendix XXII.
Table 12: Construct Validity - Correlations of open-ended responses with anxiety ratings on 
the IBPQ.
Open-ended Range- Mean Number of
responses correlation correlation p<.Ol
correlated coefficients (SD)' values (%)
with anxiety .32-.81 .62 (0.12) 13 (93)
standard deviation
Correlation coefficients ranged from .32 - .81, and 13 of the 14 correlations were significant at 
p<.OI, the other correlation being significant atp<.05.
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3.2.6. Concurrent Validity. Ratings of belief in becoming ill, and belief in dying were 
correlated with open-ended responses, to see if more severe catastrophization responses, 
reflecting thoughts about becoming more ill or dying for each item on the IBPQ, were 
accompanied by more severe specific ratings of these constructs on the questionaire. Due to 
open-ended responses being on an ordinal scale, and not being normally distributed, Spearmans 
Correlation coefficients were calculated arid are shown in Table 13. A table of all correlation 
coefficients and significance levels for individual items is presented in Appendix XXIII.
Table 13: Concurrent Validity: Correlations of open-ended responses with ratings of belief in 
becoming ill; and belief in dying, for all participants.
Open-ended 
responses 
correl. with:
- belieflillness
beliefldying
Range- 
correlation 
coefficients
Mean
correlation
(SD)'
Number of 
;7<.01 
values (%)
.33-.84  
,33 - .76
.58(0,14) 
.55 (0.12)
13 (93) 
12 (86)
standard deviation
Correlation coefficients ranged from .33 to .84 when open-ended responses were correlated with 
ratings of belief in becoming ill, and belief in dying, and all correlations were significant at à 
level of^<.05, with an overall 90% of correlations being significant at a level of/?<.01.
The statistical analyses presented in the previous section indicate that the IBPQ has favourable 
reliability and validity. However, in the light of the data presented, the results of the analyses of 
the following hypotheses should be viewed with caution, as further investigation is needed 
before a conclusive statement can be made regarding exact reliability and validity of individual 
items on the IBPQ, and the questionnaire as a whole.
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33 INVESTIGATION OF HYPOTHESES
33.1. Hypothesis 1: A high prevalence of clinically significant anxiety will be found in a 
sample of COPD patients.
A summary of mean total HADS scores, and the number of participants scoring in each 
category of severity is presented in Table 14.
Table 14: Summary of HADS scores for participants, with ranges of clinical significance.
Mean
HADS**
(SD)'
HADS severity categories; (number & %) Total 
above cut­
off score®
Mild
(8-10)
Moderate
(11-14)
Severe
(15-21)
Female (n = l9 ) 8.5 (3.7) 9 (47.4) 5 (26.3) 0 (0) 14 (73.7)
Male (n = l8 ) 7.1 (4.2) 2 (11.1) 4 (22.2) 1 (5.6) 7 (38.9)
Total (n=37)
1 . j  'J T j— ---
7.8 (4.0) 11 (29.7) 9 (24.3) . 1 (2.7) 21 (56,8)
The mean HADS score for the whole sample was 7.8 (SD=4.0; range=0-15). Of these, 21 
participants (57%) scored above the cut-off of >6 for chnically significant anxiety, 67% of this 
figure were female. There was one score in the severe anxiety range (15-21), and 9 participants 
(24%) scored in the moderate range. The authors of the scale (Zigmond and Snaith, 1983) state 
that for research purposes, it may be useful to include only data from the upper end of the mild 
(borderline) range to eliminate the likelihood of a high proportion of false positive diagnoses. 
Without the data from the 11 participants with scores of 8-10, 10 participants (27% of the 
sample) remained within the range of moderate to severe (probable) clinical significance for 
anxiety.
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3.3.2 Hypothesis 2: The presence of more severe catastrophic thoughts will be related to 
higher levels of (a) generalised anxiety (HADS anxiety) and (b) anxiety ratings on the 
IBPQ.
3.3.2(a) Mean total catastrophic thought ratings were correlated with HADS anxiety scores for 
each participant. A Spearmans Correlational analysis was used as a Kolgomorov-Smimoff 
Goodness of Fit test indicated that the distribution of means of catastrophic thought ratings was 
not normal. Correlations were also carried out for catastrophic thought ratings to symptoms in 
‘safe’ and ‘unsafe’ situations separately. A summary of these correlations is presented in Table 15.
Table 15: Correlations of open-ended responses (severity of catastrophic thought ratings) 
with HADS scores
Correlations of severity of Correlation
catastrophic thoughts with 
HADS“ scores for:
coefficient
- all 14 items .49***
- ‘safe situation items 2 ins
- ‘unsafe’ situation items .54****
'Hospital Anxiety and Depression Scale
A correlation coefficient of .49 (p<.001) was obtained for the correlation of catastrophic 
thoughts with HADS scores. When the correlation was repeated using ratings of catastrophic 
thoughts from ‘safe’ and ‘unsafe’ situations separately, coefficients of .21 and 0.54 respectively, 
were obtained, the former being non-significant, and the latter being highly significant at 
/K  OOOl. The results of the correlation of ‘all catastrophic thoughts’ with HADS scores 
supports the hypothesis that more severe catastrophic thoughts are related to higher levels of
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generalised anxiety (HADS anxiety). This relationship is also true for catastrophic thoughts to 
symptoms made in ‘unsafe’ situations, but not for thoughts relating to ‘safe’ situations.
33.2(b) The mean total of open-ended responses (catastrophic thought ratings) was correlated 
with a single mean of the anxiety ratings for all 14 items on the IBPQ for each participant. As 
before, a Spearmans Correlation was calculated due to the distribution of open-ended responses 
not being normal. Correlation coefficients were also calculated for anxiety ratings with 
catastrophization scores, for the seven ‘safe’ and the seven ‘unsafe’ situations separately. The 
results of these analyses are presented in Table 16.
Table 16: Correlations of catastrophic thoughts with anxiety ratings on the IBPQ.
Correlations of severity of Correlation
catastrophic thoughts with coefficient
anxiety ratings on IBPQ for:
-all  14 items .80****
- ‘safe situation items .67****
- ‘unsafe’ situation items 73****
IBPQ = Interpretation of Breathing Problems Questionnaire
When open-ended responses (severity of catastrophic thoughts) were correlated with anxiety 
ratings, correlation coefficients of .8, .7 and .7 were obtained for all 14 items, ‘safe’, and 
‘unsafe’ situations respectively. All correlations were highly significant at the /?<.0001 level, 
supporting the hypothesis that more severe catastrophic thoughts are related to higher anxiety 
ratings on the IBPQ.
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3.33 Hypothesis 3: In situations that are perceived as being more threatening (‘unsafe’), 
participants are more likely to, (a) have more severe catastrophic thoughts; and (b) report 
higher levels of anxiety in response to symptoms, than in situations perceived as less 
threatening.
33.3a The means of open-ended response ratings to symptoms presented in ‘safe’ and ‘unsafe’ 
situations were calculated, and compared using a Wilcoxon Matched-Pairs Signed-Ranks test, 
(one-tailed), as the data was shown not to be normally distributed using a Kolgomorov- 
Smimoff Goodness of Fit test. The means of catastrophic thought ratings in ‘safe’ and ‘unsafe’ 
situations were 1.27 (SD=.63) and 1.88 (SD=.38) respectively, and a highly significant 
difference was found between catastrophic responses in the two situations (z = -4.88,/?<.0001), 
thus supporting the hypothesis that more severe catastrophic thoughts will be experienced in 
threatening situations than in ‘safer’ ones.
3.3.3b Due to the normal distribution of scores (indicated by a Kolgomorov-Smimoff 
Goodness of Fit test), a t-test for paired samples was used to compare ratings of anxiety made in 
‘safe’ and ‘unsafe’ situations. The means of anxiety ratings in 'safe' and 'unsafe' situations were 
3.12 (SD=1.79) and 5.18 (SD=2.30) respectively. A t-value of 9.78 (p<.0001; d.f.=36) was 
obtained, again, indicating a highly significant difference between ratings of anxiety in each of 
these conditions, and thus supporting the hypothesis that more severe catastrophic thoughts will 
be experienced in threatening situations than in ‘safer’ ones.
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33.4 Hypothesis 4: Severity of catastrophic thoughts (open-ended responses) will predict 
more of the variance in anxiety than other variables associated with anxiety, including 
disease severity, duration of COPD, age, and satisfaction with social support
Three stepwise multiple regressions were carried out to ascertain the factors that would account 
for a proportion of the variability in the dependent variable of ‘anxiety’. In all three regression 
analyses, the dependent variable was anxiety, assessed using the HADS. Independent variables 
entered into the regression were age, duration of illness (years), satisfaction with social support 
(measured on the SSQ6), severity of illness (measured on the SGRQ), and, in the first multiple 
regression, total severity of catastrophic thought ratings, in the second, severity of catastrophic 
thought ratings in 'safe' situations, and in the third, severity of catastrophic thought ratings in 
'unsafe' situations. The results of these regression analyses is presented in Table 17.
Table 17: Summary of the three multiple regressions showing independent variables that 
explain significant amounts of the variance in the HADS score
#
Dependent
Variable
Independent variables entered 
into stepwise regression 
equation that were significant
B . T
R^ d.f.
F
(i) HADS anx.
1. Social support satisfaction
2. All catastrophic thoughts
-1.34
2.81
-2.94**
2.18*
0.39 2,34 10.99***
(ii) HADS anx. 1. Social support satisfaction -1.73 -3.94*** 0.31 1,35 15.55***
(iü) HADS anx.
1. Catastrophic thoughts - 
unsafe situations
2. Social support satisfaction
2.43
-1.49
2.56*
-2.46*
0.42 2,34 12.27***
*p<.05; **/7<.01; ***/7<.001 
# - Where all independent variables put forward for entry into each of the 2 stepwise regressions are: 
Age; Duration of illness; Satisfaction with social support; Illness severity and:
(i) All catastrophic thoughts
(ii) Catastrophic thoughts in ‘safe* situations
(iii) Catastrophic thoughts in ‘unsafe situations*
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The multiple regressions provided a summary of the variables that explained a significant 
proportion of the variability of HADS anxiety. In all three regressions, age, duration of illness, 
and severity of illness, did not add significantly to an explanation of the variance in the HADS 
anxiety score.
(i) In the first analysis where the mean of ‘Ë1 catastrophic thoughts’ was entered as one of the 
independent variables, social support was shown to be most strongly related to HADS anxiety, 
with a negative T value of -2.94 (p<.006). Catastrophic thoughts were also shown to relate 
significantly to the HADS score, although less strongly than social support (T=2.18; p<.04). 
Together, these 2 variables explained 39% of the variance of HADS anxiety, (R^=0.39; 
d.f.=2,34;p<.0002).
(ii) In the second analysis where catastrophic thoughts relating to symptoms in ‘safe’ situations 
were included as one of the five independent variables, only social support was significant in 
explaining the variance of the HADS score, with a T-value of -1.73 (p<.0004), accounting for 
31% of the variance (R^=0.31; F=15.55; d.f.=l,35; p<.0004).
(iii) The final analysis included catastrophic thoughts relating to symptoms in ‘unsafe’ 
situations, which was the most strongly related independent variable to HADS anxiety (T=2.56; 
/7<.015). Social support explained a slightly lesser amount of the variance (T = -2.49; /?<.019), 
and together with catastrophic thoughts, explained around 42% of the variance of the HADS 
score (R^=0.42; F=12.27; d.f.=2,34; p<.0001).
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On the above analyses, the positive B-values of 2.81 and 2.43 for the catastrophic thought 
variables on analyses (i) and (iii), indicate a strong positive relationship between HADS anxiety 
and severity of catastrophic thoughts, with a higher HADS anxiety score correlating with more 
severe catastrophic thoughts. The negative B-values on all three analyses, indicate a strong 
negative relationship between HADS anxiety and satisfaction with social support, where higher 
HADS anxiety scores were strongly related to less satisfaction with social support.
The results of these regressions support the hypothesis that catastrophic thoughts are more 
predictive of anxiety, (in this case generalised anxiety assessed on the HADS), than severity and 
duration of illness, and age. However, contrary to the hypothesis, satisfaction with social 
support also explained a significant amount of the variance in the HADS score, particularly 
when ‘catastrophic thoughts relating to symptoms experienced in ‘safe’ situations’ was entered 
as an independent variable.
Three further multiple regressions were carried out, with the mean anxiety rating scores from 
the IBPQ as the dependent variable. Independent variables remained the same as those in the 
first set of regression analyses, with open-ended responses (catastrophic thoughts) in relation to
(i) all, (ii) safe, and (iii) unsafe conditions being the only independent variable to change in each 
of the 3 analyses. Table 18 summarises the results of these analyses.
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Table 18: Summary of multiple regressions showing independent variables that explain a 
significant amount of the variance in mean anxiety rating score on the IBPQ
#
Dependent
Variable
Independent variables entered 
into stepwise regression 
equation that were significant
B T
d.f. F
(i)
Anxiety 
ratings on 
IBPQ
1. All catastrophic thoughts 3.18 6.39*+** 0.54 1,35 40.9****
(ii)
Anxiety 
ratings on 
IBPQ
1. Catastrophic thoughts - 
- safe situations
2. Social support satisfaction
3.02
-0.42
4.64****
-2.16*
0.47 2,34 14.8****
(iii)
Anxiety 
ratings on 
IBPQ
1. Catastrophic thoughts - 
unsafe situations 2.11 5.44**** 0.46 1,35 29.5****
*/i<.05; ****/K.0001
# - Where all independent variables put forward for entry into each of the 3 stepwise regressions are: 
duration of illness; satisfaction with social support; illness severity and:
(i) all catastrophic thoughts
(ii) catastrophic thoughts in ‘safe* situations
(iii) catastrophic thoughts in ‘unsafe situations*
As in the multiple regression analyses in section 3.3.4a, age, duration of illness, and severity of 
illness, did not add significantly to the explanation of variance in anxiety , ratings after more 
significant variables had been entered into the equation.
/
(i) In the first analysis, severity of ‘catastrophic thoughts in all 14 situations’ was the only 
independent variable that accounted for variance in the anxiety score on the IBPQ, with a T 
value of 6.39 (p<.Q001). Catastrophic thoughts accounted for 54% of the anxiety rating 
variance (R^-0.54; F~40.89; d . f - 1,35) at a significance level of /?-.0001. Social support did 
not contribute to an explanation of the variance.
(ii) In second analysis, the mean of ‘severity of catastrophic thoughts relating to symptoms in 
safe situations’ was the independent variable that most significantly explained the variance of 
anxiety ratings on the IBPQ, with a T-value of 4.64 (p<.0001). Satisfaction with social support
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was also related, but less significantly than catastrophic thoughts, (T = -2.16; p< M ). Together, 
these variables accounted for 47% of the variance (R^=0.47; F=14.81; d.f.=2,34) at a 
significance level of/?<.0001.
(iii) In the final analysis, ‘catastrophic thoughts to symptoms in ‘unsafe’ situations’ was the 
only independent variable related to anxiety ratings on the IBPQ (T=5.44; /?<.0001), explaining 
around 46% of the variance of the anxiety score (R^=0.46; F=29.54; d.f.=l,35; /?<.0001).
As before, the positive B-values of 3.18, 3.02, and 2.11 on analyses (i), (ii), and (iii) 
respectively, indicated a strong positive relationship between catastrophic thoughts and anxiety 
ratings, with more severe catastrophic thoughts correlating with higher anxiety scores on the 
IBPQ. The negative B-value on the second analysis indicates a negative relationship between 
satisfaction with social support and anxiety.
The results of these regressions also support the hypothesis that catastrophic thoughts are more 
predictive of anxiety, (in this case, anxiety ratings made to the experience of a range of 
symptoms in a range of situations on the IBPQ), than disease severity, age, and duration of 
illness. As before, satisfaction with social support also explained a significant amount of the 
variance in the anxiety score, when ‘catastrophic thoughts in response to safe situations’ was 
entered an independent variable, but was not relevant in the other two regressions. 
Cognitions were more strongly predictive of anxiety ratings measured on the IBPQ than to 
HADS anxiety.
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3.4 Additional analysis: Although there was not a direct hypothesis relating to participants’ 
‘avoidance’ scores on the IBPQ, it was felt that it would be of interest to assess whether there 
was a significant difference between avoidance of situations in ‘safe’ and ‘unsafe’ situations. In 
this analysis, a non-parametric test was considered most appropriate as there were only two 
possible responses to be taken into account (yes/no), hence a Wilcoxon Matched-Pairs signed- 
ranks test was used to analyse the data. The mean of scores for the seven ‘safe’ situations 
(mean number of ‘safe’ situations avoided) was 1.03 (SD=1.72; range=0-7), and for ‘unsafe’ 
situations, the mean number of situations avoided was 3.54 (SD=2.24; range=0-7). A highly 
significant difference was found between avoidance of ‘safe’ and ‘unsafe’ situations, with a z- 
score of -4.94 (jcK.OOOl), indicating that there was significantly more avoidance of ‘unsafe’ 
situations than of ‘safe’.
Section 4
DISCUSSION
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4. DISCUSSION
Overview of Discussion There were two main aims of this study. The first was to develop a 
questionnaire that could be used to elicit cognitions and ratings of predicted anxiety, related to a 
variety of symptoms associated with COPD in a range of situations. The second aim was to 
investigate a number of hypotheses about the relationship of cognitions, in particular 
catastrophic thoughts, to anxiety. This was done using the new questionnaire (the IBPQ) in 
addition to three other standardised questionnaires and a background information sheet. 
Investigations of the reliability and validity of the IBPQ will be presented first, with discussion 
about how the psychometric properties of the questionnaire can be improved in the future. The 
second section of the discussion will present a summary of the results from the testing of the 
hypotheses, which will be followed by a discussion of methodological considerations. Finally, 
interpretation of the main research findings, with implications for clinical practice and future 
research will be discussed in the light of the results of this study.
4.1 SUMMARY OF RESEARCH FINDINGS
4.1.1 Psychometric Properties of the IBPQ:
Thé range of situations described in the 14 items on the IBPQ were rated for safety, and a 
significant difference in safety was found between seven of the items rated as ‘more safe’ and 
seven items rated as ‘more unsafe’. The effect of situation on cognitions and anxiety was 
therefore included in the analyses of hypotheses.
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4.1.1.1 Reliability: The analyses carried out indicate that the reliability of the IBPQ was good.
Inter-rater reliability for the IBPQ was high, with 90% agreement (Kappa = 0.83) between the 
two independent judges for categorising open-ended responses according to their level of 
severity. Internal consistency of the IBPQ was extremely high (Cronbach's alpha=0.90) when 
responses to each of the 14 open-ended questions for each participant were assessed for 
homogeneity.
Test-retest reliability was high for most of the open-ended items, with significant correlations 
fur five of the seven items mcoiporating 'safe' situations, and for all items incorporating 'unsafe' 
situations. Despite the non-significant correlations of two items, 14 (78%) of the 18 participants 
who completed the retest condition actually rated them the same as they had done in the original 
condition. However, the Kendalls-Tau analysis which was chosen to assess the correlations 
takes into account the degree of variance within the total responses made to each item, and it is 
likely that the generally lower significance of items in the 'safe' condition is attributable to the 
fact that most responses to these seven items were non-catastrophic. This resulted in less 
variance in responses as a whole. Test-retest rehability for ratings of anxiety, belief in 
becoming ill, and behef in dying, were generally high. On the items that showed differences in 
test-retest analysis, ratings and open-ended responses were generally higher at the second 
testing. This may have been due, in part, to the psychology trainee not being present in this 
condition, whereas she was present throughout all initial testing. Participants may have felt 
more confident in their ability to cope with the situations presented when in the presence of 
another person. Inclusion of more participants in tlic retest uundiliun might also have increased 
the possibility of a significant finding for test-retest reliabihty.
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4.1.1.2 Validity: Construct validity was assessed by correlating anxiety ratings on the IBPQ 
with HADS anxiety scores. When the outlying scores of one participant were excluded from 
the data sample, all but one (which was non-significant) of the correlations were significant at 
p<.05. Ratings of anxiety were also correlated with open-ended responses, as a further measure 
of constmct validity, with all but one correlation (p<.05) significant at /K.Ol. Concurrent 
validity was assessed by correlating open-ended responses (severity of catastrophic thought) 
with behef in becoming ill and belief in dying. All correlations were significant at p<0.05, 
which further supports the validity of participants' responses to questions designed to elicit 
cognitions.
It can be concluded from the analyses carried out, that the IBPQ has good reliability and 
vahdity as a measure of catastrophic cognitions, and as a measure of anxiety associated with 
those cognitions. Test-retest reliability was generally high, but may have been affected by the 
differences in conditions between the initial and second testing. Reliability may also have been 
further enhanced by inclusion of more participants in the retest condition. The questionnaire 
was effective in eliciting cognitions from participants, but for some people, further explanation 
of how to respond to open-ended questions was required before they were able to. Also, some 
participants spontaneously reported catastrophic cognitions in conversation, e.g. 'I never go out 
because I know I'd panic on my own', but their responses on the IBPQ did not reflect this 
severity of catastrophization. It may be that the items on the questionnaire were not appropriate 
stimuli to elicit all catastrophic thoughts, and for these people, a structured interview may elicit 
cognitions more readily. Further assessment is needed to ascertain whether elimination of items 
which were less significantly reliable or valid from the questionnaire would increase the overall 
psychometric properties of the IBPQ.
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4.1.2 Summary of Investigations of Hypotheses: Data on 37 out-patients with COPD 
highlighted a high prevalence of clinically significant anxiety. Using the HADS, more than half 
the sample were identified as suffering from mild to moderate anxiety, and even with the 
exclusion of data from participants who scored less than 11 (lower end of the moderate range), 
10 people (27% of the sample) had anxiety scores within the moderate (probable) anxiety range. 
Surveys of the general population suggest a prevalence rate of around 10% for such anxiety 
problems (Weissman & Merikangas, 1986). The figure obtained was comparable to that 
reported by Yellowlees et a l (1987) of 24%, and PorzeUus et a l (1992) of 37%, but was much 
higher tlian tlie figure of 9% reported by van Pcski Oustcibaan et al (1996). In comparison 
with studies of anxiety in other medical populations which also used the HADS, the total figure 
(including scores in the 'mild' range) obtained in the current study is slightly higher. 
Chandarana, Eals, Steingart, and Bellamy (1987) reported that 21% of their sample of patients 
with rheumatoid arthritis scored above the HADS cut-off of 8/9, with 19% of their sample 
scoring in the moderate-severe range of anxiety. Another study by Ford, Levris and Fallowfield 
(1995) reported that 26% of their sample of newly referred patients with cancer scored above 
the cut-off for anxiety on the HADS.
More severe catastrophic thoughts were significantly correlated /with higher levels of both 
generalized anxiety (measured on the HADS scale), and situation-specific anxiety ratings on the 
IBPQ. For both measures of anxiety, this relationship was stronger for catastrophic thoughts in 
relation to symptoms experienced in 'unsafe' situations, than in 'safe', which was not 
significantly correlated with HADS anxiety. Significantly more avoidance was found for 
'unsafe' than for 'safe' situations amongst participants in this study.
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Analysis of open-ended responses showed that catastrophic thoughts were significantly more 
severe in response to COPD-related symptoms presented in 'unsafe' situations than in 'safe', 
indicating that situational variables may act as moderators for catastrophic cognitions. Anxiety 
ratings on the IBPQ were also significantly higher in 'unsafe' situations.
The results of the multiple regression analyses indicate that 'catastrophic thoughts' explained a 
significant amount of the variance in both generalized anxiety as measured on the HADS, and 
in anxiety ratings related to symptoms in a range of specific situations, measured on the IBPQ. 
Age, and severity and duration of ilhiess, did not contribute significtmlly to either measure of 
anxiety. Social support was also important, explaining more of the variance in generalized 
(HADS) anxiety than cognitions when 'all catastrophic thoughts' 'was entered into the 
regression, and being the only significant contributer to HADS anxiety scores when 
'catastrophic thoughts in relation to 'safe' situations' was entered. However, social support was 
less important in predicting anxiety than severity of catastrophic thoughts in all three of the 
analyses performed when anxiety ratings on the IBPQ was entered as the dependent variable. 
These results support the hypothesis that catastrophic cognitions are a significant predictor of 
anxiety, both generalized and more specific.
In summary, all the hypotheses appear to have been upheld. A high prevalence of anxiety was 
found, which was higher than those reported in recent studies with people with COPD, and 
studies ^ t h  patients with other chronic medical conditions. More severe catastrophic thoughts 
were strongly correlated with both generalised anxiety and anxiety ratings on the IBPQ, and 
thoughts were more catastrophic in ‘unsafe’ situations than in ‘safe’. Regression analyses
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identified 'catastrophic cognitions' as a strong predictor of both generalized and more specific 
anxiety, and this relationship was stronger for anxiety ratings on the IBPQ than for anxiety on 
the HADS. However, contrary to the hypothesis, satisfaction with social support was a 
particularly strong predictor of HADS anxiety,, when ‘catastrophic thoughts in safe situations’ 
was included as an independent variable. However, cognitions explained more of the variance 
in generalized anxiety in unsafe situations than social support, raising the possibihty that 
situational variables may be important moderators of severity of catastrophization, thereby 
mediating levels of anxiety.
4.2 METHODOLOGICAL CONSIDERATIONS
There were several limitations to this study. First, because of the high ratio of predictor 
variables to sample size, the results of the multiple regression analyses must be treated with
caution. In addition to these problems, particular methodological concerns for the study include
1
a relatively small sample size with possible biases in composition, and specific concerns about 
the appropriateness of the measures chosen. These will be discussed in more detail below.
4.2.1 The Sample
The sample size for this study was relatively small, making it difficult to draw firm conclusions 
from the results. Also, the self-selecting nature of the sample calls into question the 
representativeness of the findings, particularly for the prevalence of anxiety amongst this group. 
All the people contacted attended chest clinics, asthma clinics, or were involved with the 
pulmonary rehabilitation programme. It is likely that this presented a bias in the sample even 
before self-selection took place, as these people were more likely to have more severe 
symptoms, and, particularly for those attending rehabilitation programmes, may experience
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more anxiety and cope less adequately with their illness than is really typical of this patient 
group. This bias may account for the unusually high level of anxiety reported in this study, 
which exceeds levels reported by some other authors (e.g. Prevalence rate of 16% - Karagji et 
a l, 1990). A large group of patients with COPD, particularly with milder forms of asthma, do 
not require continuing contact with these specialist services, and therefore would not have been 
considered by the physicians who selected suitable patients for the study. Of those who were 
contacted, 43% declined to take part, and of those who replied to the initial letter but declined, 
no reasons were given for this decision. It may be therefore, that the present sample did not 
include some of those who coped well with respiratoiy disease and did not experience 
significant anxiety. It is also possible that people who experienced significant anxiety may have 
declined to take part, if they felt that focusing on their respiratory problems may have increased 
their anxiety.
The gender spread amongst the sample was very evenly split, but age effects were harder to 
determine, as relatively few people took part who were below the age of 40. This was reflective 
of the later age of onset of some illnesses associated with COPD (e.g. bronchitis and/or 
emphysema). Clearly, a larger sample, which included a greater representation fi-om patients 
whose experience of anxiety included those with low anxiety as well as those with extreme 
anxiety, would give a more representative view of the true nature of the experience of anxiety 
amongst this group of people.
4.2.2 The Measures
With regard to the measure of illness severity used in this study (SGRQ), it has been 
demonstrated to be highly correlated with actual physiological impairment, and was therefore
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likely to be reliable self-report measure of severity. However, it would have been useful to 
include additional physiological respiratory function tests, such as Forced Expiratory Volume 
(FEVl) and Forced Vital Capacity (FVC) which are both spirometry measures of respiratory 
function, and have been used in many studies of respiratory disease (Porzehus et a l, 1992; van 
Peski-Oosterbaan et a l, 1996). Unfortunately, the author did not have access to, or the training 
to use these types of measure, and figures that could have been obtained from medical notes 
would have been out of date, as lung function may fluctuate. Other studies (Maes and 
Schlosser, 1988) have used a combination of amount and type of medication, number of 
hospital visits in the last year and duration of ilhiess as a measure of severity. This was not used 
in this study as some studies have shown the resulting value is potentially less rehable as 
medication usage and visits to hospital are affected by other variables such as level of anxiety 
and adaptive coping mechanisms employed by the patient, regardless of actual impairment 
(Kinsman et a l , 1980; Kaptein et a l , 1988).
In previous studies (Porzelius et a l, 1992; Carr et a l, 1994) which have looked at the role of 
cognitions in anxiety and panic amongst patients with COPD, standardized measures have been 
used to assess for the presence of catastrophic thinking, such as the Agoraphobic Cognitions 
Questionnaire, and the Body Sensations Questionnaire, both developed by Chambless et a l, 
(1984). Use of these questionnaires may have been helpful in providing data which could be 
compared with that obtained in other studies, and may also have introduced another measure by 
which construct vahdity of the IBPQ could have been assessed. However, the decision not to 
use them was based on the faet that these measures were developed for therapy with other 
patient groups, and not specifically for people with respiratory disease. Clinical observations 
suggest that in addition to more general ‘panic-related’ cognitions, illness-specific cognitions
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may be present in patients with COPD, and general questionnaires may not be sensitive to these, 
although they may have provided useful information on the extent of general catastrophization.
Cognitions and ratings of anxiety ehcited by the IBPQ provided useful information on what 
participants anticipated they would think or do if they experienced the symptoms described in a 
range of situations presented. Unfortunately, practical limitations of a study such as this meant 
that there could be no in vivo assessment of thought, emotion or behaviour. This is a weakness 
of many questionnaires of this type, which rely on presentation of hypothetical scenarios to 
elicit thoughts, emotions and beliaviours, (for example. The Budy Sensations Interpretation 
Questionnaire (Clark, Salkovskis, Ost, Westling, Koehler, Jeavons, and Gelder, (submitted), on 
which the format and structure of the IBPQ was based).
The measure of generahzed anxiety used in this study (HADS) was chosen because of it's 
appropriateness and acceptability to patients who have physical illness (Zigmond and Snaith, 
1983). However, it is difficult to compare anxiety prevalence figures fi-om this study to those in 
other studies with people with COPD, as a range of different measures have been used to assess 
anxiety levels in the various studies. For example, Yellowlees and colleagues (Yellowlees et 
a l, 1987), used a psychiatric interview to diagnose prevalence rates of 24% for panic disorder, 
with higher reported figures for anxiety, while much lower rates have been reported when other 
measures, such as the Stait-trait Inventory have been used (Light, Merrill, Despars, Gordon, & 
Mutalipassi, 1985). Also, in many studies, (e.g. van Peski-Oosterbaan et a l, 1996), prevalence 
figures for panic disorder are given, but there is less information on prevalence of other anxiety 
disorders. For valid comparisons to be made between studies, there needs to be greater use of 
equivalent questionnaires for measuring a particular variable. Related to this, it may have been
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helpful to assess for panic disorder in the current study, as it is possible that some participants 
may experience more generalised panic-related cognitions in response to a variety of other 
symptoms, possibly unrelated to the respiratory disease (e.g. symptoms such as "heart racing', 
palpitations, (Clark, 1986) in the absence of any respiratory-specific symptomatology).
4.3 INTERPRETATION OF RESEARCH FINDINGS
The prevalence of moderate to severe anxiety identified amongst this population of patients 
with COPD was comparable to the findings of Yellowlees et al (1987). However, prevalence 
figures in both this and the current study were higher than those reported in other studies (e.g. 
Karagji et a l, 1988). The identification of such a high prevalence of anxiety is of particular 
concern as the experience of anxiety and panic has been found to worsen episodes of breathing 
difficulty, interfering with effective treatment (e.g. appropriate inhaler use), and potentially 
worsening the attack (Creer & Wigal, 1989). Kinsman et al (1980) identified two types of 
anxiety associated with COPD; first, anxiety focused directly upon breathing difficulties, and 
second, anxiety characteristic of the person in many situations, regardless of the illness. Both 
forms of anxiety were associated with inappropriate excessive medication use in asthmatic in­
patients, and greater levels of rehospitahzation than for patients with lower levels of anxiety.
The finding that more severe catastrophic cognitions were significantly correlated with anxiety 
concurs with the findings of previous studies. Porzelius and colleagues (Porzehus et a l, 1992) 
found a strong association between anxiety and panic, with a high frequency of fear-provoking 
thoughts and concern with bodily symptoms (measured on the Agoraphobic Cognitions 
questionnaire (ACQ) and the Bodily Sensations questionnaire (BSQ)). In the current study.
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cognitions were elicited from open-ended questions which presented a range of COPD-related 
symptoms in 'safe' and "unsafe' situations. This latter measure may therefore have been more specific 
to the subjective experience of COPD symptonis than those used in the study by Porzelius et a l, 
which were developed for use with other clinical populations. Despite these methodological 
differences, the association between severity of catastrophic thoughts and anxiety remained strong in 
both studies.
Regression analyses indicated a clear predictive relationship between catastrophic cognitions and 
anxiety, which was stronger for specific anxiety ratings on the IBPQ than on the HADS measure of 
generalised anxiety. A recent study by Carr and colleagues (Carr et a l, 1995) also identified this 
predictive association, using a more general measure of catastrophic cognitions (ACQ). As in the 
current study, cognitions remained strongly predictive of anxiety, even when the frequency of 
dyspnea, severity of pulmonary impairment, and demographic variables were controlled for, 
supporting the appropriateness of applying the cognitive model, with its emphasis on the importance 
of catastrophic cognitions, in explaining anxiety.
In the current study, satisfaction with social support was also found to be strongly predictive of 
generalised (HADS) anxiety. This concurs with findings in studies by Sarason et al (1987) in which 
greater perceived social support was strongly associated with anxiety, as well as depression, 
somatization, and psychological disorder. This has important implications with regards to 
therapeutic interventions aimed at reducing anxiety levels, demonstrating that in addition to 
modification of catastrophic cognitions relating to COPD symptomatology, other factors, such as 
social support, must also be addressed.
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The two measures of anxiety used in the current study assessed different aspects of anxiety, and this 
was reflected by the differences in strength of correlations and the extent to which each was 
predicted by catastrophic thoughts. The HADS reflects anxiety across a range of situations that 
occur over several days previous to assessment, but may not reflect peaks of anxiety that may be 
associated with exposure to certain symptoms and situations. The ratings of anxiety on the IBPQ 
were more specific according to symptom and the situation presented in each question. Ratings gave 
a prediction of how anxious participants felt they would be if they experienced the symptom 
presented in the situation presented. Although the association between catastrophic thoughts and 
anxiety was strong for both these measures of anxiety, the predictive relationship was stronger for 
IBPQ ratings of anxiety, which may be a reflection of how cognitions were specifically in response to 
the items presented on the questionnaire, and not more general in nature..
Both catastrophic thoughts and anxiety ratings in response to COPD symptoms in the 'unsafe' 
situations, were significantly more severe than in the safer situations. This may relate to the finding 
that there was significantly more avoidance of "unsafe' situations than of the 'safe' situations. It may 
therefore be reasonable to hypothesise that many of the people who took part in this study rarely 
exposed themselves to some of the situations described, and hence would have been unlikely to have 
experienced symptoms in these situations. Avoidance of situations in which people have 
expectations of more catastrophic outcomes in the event of experiencing COPD-related 
symptomatology may be an important, but maladaptive, coping strategy to ensure high levels of 
anxiety are avoided. Cognitions related to 'safe' situations were significantly less catastrophic than in 
unsafe situations and were not significantly correlated with (or predictive of) HADS anxiety, even
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though all seven symptoms were presented, in both categories of safety. As in the Carr et a l (1995) 
study, severity and duration of illness were not significantly predictive of either measure of anxiety, 
and together, these findings support the application of a cognitive model to the genesis of anxiety and 
panic, and may also explain the reported higher levels of social isolation amongst this population 
(Kaplan et a l , 1988; Lehrer et a l , 1992).
The belief in more catastrophic consequences in ‘unsafe’ situations, and subsequent avoidance 
behaviour, may therefore reflect an unrealistic self-appraisal of ability to cope with symptoms in 
certain circumstances (e.g. being away from home without familiar people around). This has 
important consequences for therapy with people who have anxiety related to COPD. While HADS 
anxiety may reflect high levels of generalised anxiety, this may be masked in some people by 
avoidance behaviour which moderates exposure to situations in which catastrophic thoughts and 
consequent anxiety may be experienced In these people, anxiety may be specifically related to the 
experience of symptoms in circumstances where they feel less confident, and may not be apparent 
without more specific assessment. An understanding of the thoughts associated with a patients' 
anticipated anxiety, assessed through a measure such as the IBPQ, may provide a valuable insight 
into the potential of an individual to become anxious in response to catastrophic thoughts about 
COPD symptoms.
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Agle and Baum (1977) reported that patients with high levels of anxiety were less likely to 
benefit from rehabilitation programmes. Clinical experience with such programmes suggests 
that despite a reported increase in ability to cope in the home environment following 
participation in a rehabilitation programme, this improvement is often not reported .to have 
generalised to situations where familiar people are not around or the patient is away fix)m the 
home or a medical environment. The results of the current study may lead one to hypothesise 
that one reason for non-generalisability of benefits of rehabilitation in some people with COPD, 
may be due to anxiety-provoking catastrophic cognitions that have not been directly addressed, 
or even identified. This may result in impaired quality of life, wliich lias been reported by 
numerous authors (Carr et al, 1995; Kinsman et a/., 1980; Lehrer et a l, 1992), and this would 
seem a valid focus for therapy.
4.4 CLINICAL IMPLICATIONS
Although treatment for COPD sufferers has improved substantially over the last three decades, 
therapeutic measures are effective only for symptom alleviation, and as yet, no cure has been 
found for the disease (Lee et al, 1991). Interventions therefore focus on minimizing the impact 
of the disability on the patients life. Even with improved preventative and ameliorative 
medication, patients' quality of life is still significantly impaired, with reports of more 
depression, anger, and fatigue than in a healthy population (Lee et a l, 1991).
The results of this study highlight areas for which there are important therapeutic imphcations. 
The finding that more severe catastrophic thoughts are predictive of anxiety, provides a useful 
focus for intervention, particularly in the context of knowledge about other important factors
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which may moderate the severity of catastrophic thoughts, such as the perceived safety of the 
environment in \riiich symptoms may occur. Results from completion of the IBPQ suggested 
that the high rates of avoidance of ‘unsafe’ situations in particular, may occur because of the 
anticipated anxiety associated with the possibility of experiencing symptoms related to COPD 
in situations where participants believed they would be at greater risk of becoming more ill, or 
even dying. The fact that severity of illness was not found to be an important factor in 
predicting anxiety in this study, as well as in previous studies (Carr et a l, 1995), provides 
further evidence that some people may avoid certain situations or activities because of 
unrealistic thoughts about the consequences of experiencing symptoms at these times.
An important goal of therapy then, would be to reduce the likelihood of a patient experiencing 
unnecessary self-imposed restrictions, unrelated to the actual severity of their illness, 
contributing to a lower quality of life, reduced opportunity for social support from community 
sources, and maintenance of unrealistic catastrophic cognitions about the consequences of 
symptoms. From studies with patients with other medical illnesses, catastrophizing has been 
shown to be an important factor in poor coping, and to be strongly related to greater disability 
(Petrie et a l, 1995; Smith et a l, 1986). Therapeutically, identification of patients with 
catastrophic cognitions and/or high levels of anxiety, is important in order that these patients 
may be targeted for therapy. An important focus for therapy would be on reduction of specific 
catastrophic cognitions associated with the illness, as opposed to using standard anxiety 
management techniques in which the focus may be on reducing more general anxiety. While 
high levels of generalised (HADS) anxiety may be a useful indication that more specific anxiety 
related to the respiratory disease may be present, a more specific evaluation of anxiety and 
particularly catastrophic thinking in relation to symptoms, is needed.
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Since the physiological sensations are not likely to be eliminated, cognitive modification is an 
important treatment option for these patients. This treatment modality presents some unique 
challenges since treatment cannot consist of selective exposure to the bodily sensations which 
are chronic, or to hyperventilation, which may be hazardous. The severity of symptoms 
associated with COPD means that both catastrophic and depressogenic forms of appraisal have 
some basis in reahty. However, cognitive-behavioural treatment can be helpful in obtaining a 
realistic sense of danger and help the patients to cope with their physical condition without the 
emotional suffering of panic or depression.
The focus of intervention may then be on cognitive restructuring of unrealistic or unhelpful 
catastrophic thoughts, which could then be tested out behaviourally through graded exposure to 
avoided situations (e.g. being away from the home or a medical environment) or circumstances 
(e.g. being alone). This type of intervention could be implemented through individual therapy, 
or in a group setting, such as through pulmonary rehabilitation groups, for which there may be 
the added benefit of providing additional social support through contact with other people with 
mutual experiences (Sarason et al., 1988).
Pulmonary rehabilitation programmes constitute a comprehensive treatment approach based on 
symptom management and the promotion of energy and health. They usually comprise patient 
and family education, breathing training, systematic exercise, and patient support, provided by a 
multidisciplinary team of health professionals (Petty, 1993). There are obvious benefits to 
patients' quality of life from participation in programmes such as these, but personal clinical 
experience has also shown that these benefits often do not generalise to settings outside of the 
home environment or the medical unit in which programmes are usually run. Anxiety is rarely
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treated using a structured cognitive approach, and the presence of catastrophic thinking that may 
underlie severe anxiety and maintain unrealistic beliefs , about ability to cope with symptoms 
alone or away from home, has not been addressed in the hterature on pulmonary rehabilitation.
‘Satisfaction with (general) social support’ was also a factor found to be significantly predictive 
of anxiety levels, with greater satisfaction predicting lower levels of anxiety. Studies (Sarason 
and Turk, 1983; in Sarason, Sarason and Pierce, 1988) have shown that perceived social support 
is more important than actual support with regards to adaptive coping with health problems. 
There is some evidence that family therapy, aimed at enabling the family to behave rationally 
and to optimally utilise medical services and interventions, may be associated with improved 
medication intake, and reduced impairment in daily functioning (Gustafsson, Kjellman, and 
Cederblad, 1986). Social support may be improved by helping patients with respiratory disease 
to realistically appraise their current levels of support, and providing information on social 
support networks, such as 'Breathe Easy' groups, which provide support for people with 
respiratory diseases through organised activities, providing information, and putting patients 
and their relatives in touch vsdth others.
Thus far, there have been few evaluations of cognitive-behavioural interventions with people 
with COPD, although the use of cognitive therapy as part of psychoeducational self­
management programmes for asthma has been found to be beneficial when compared with a no 
treatment control (Carr et a l, 1994; Emmelkamp and van Oppen, 1993). More research is 
needed before tlie full potential of this form of treatment can be evaluated, but the evidence 
from recent studies and the current study, of the presence of catastrophic thinking in response to
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symptoms associated with COPD, and the relation of these to anxiety, lends support to this 
approach for therapy.
4.5 SUGGESTIONS FOR FUTURE RESEARCH
Completion of this study has heralded a number of areas in which further research may further 
current knowledge about the relationship of cognitions and anxiety in people with respiratory 
disease. Some of these are outlined below.
(i) Further statistical analysis of the psychometric propeities of tlic IBPQ is needed before its 
reliability and validity can be fully reported on. It would be interesting to assess the predictive 
properties of the measure with regards to future anxiety, the potential success of a clients' 
engagement in individual therapy or a rehabilitation programme, and possible future disability 
and handicap.
(ii) Further testing of the application of the cognitive model of panic to people with COPD and 
concurrent high levels of anxiety is required. Firstly, a longitudinal design may provide more 
information than the current design which was mainly correlational. It would allow for teasing 
out of the complex inter-relationships between catastrophic thoughts, social support, anxiety, 
and behaviour, as well as allowing for evaluation of other variables that may be involved. 
Without studies of this nature, it is not possible to say whether changing catastrophic thoughts 
alone, will necessarily lead to a reduction in anxiety. Secondly, the model could be further 
tested through experimental manipulations. This may involve modifying, through focused 
psychological interventions, a particular aspect of one variable, e.g. extent of catastrophic 
cognitions, and evaluating the effect of this change on other variables.
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(iii) It may be interesting to look at whether there is variation in the applicability of the 
cognitive model, according to the specific diagnostic groupings of patients (e.g. asthma, 
emphysema, bronchitis, etc) within the wider category of COPD.
(iv) There are likely to be many other variables that may also be affected by catastrophic 
thinking which, for reasons of limitations in time, and acceptability of the study to participants, 
were not included in this study. These may include self-medication patterns, self-management, 
self-efficacy beliefs, etc.
(v) A number of other factors have been shown to be related to high anxiety amongst people 
with respiratory disease. Lelirer et al. (1993; in Carr et al., 1994) fuund that frequent experience 
of hyperventilation; reaction to asthma medications such as steroids; and negative emotion 
produced by having a chronic disease, to be implicated in provoking anxiety and other negative 
emotional states. It may be that none of these factors by itself is enough to produce anxiety, but 
in the presence of catastrophic cognitions, they could be hypothesised to increase vulnerability 
to anxiety and panic. Assessment of this hypothesis would be interesting, perhaps by 
employing a control group against which specific groups of patients could be compared.
(vi) In addition to those people who score very highly on anxiety scales, some people with high 
levels of avoidance may actually score relatively low on measures of generalized anxiety such 
as the HADSj as they are careful never to be exposed to situations they believe may have a 
dangerous outcome in the event of experiencing symptoms related to their respiratory disease. 
Further study may therefore be interesting, to see whether these people with low anxiety, have 
severe catastrophic thoughts specifically in response to COPD symptomatology.
(vii) Finally, it would be important to evaluate the involvement of otlier cinotioiial problems, 
such as depression, for which there are also reportedly higher prevalence levels than are to be 
found in the general population (Lehrer et al., 1993).
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4.6 CONCLUSIONS
The major conclusions from this study are as follows:-
1. A significantly high prevalence of anxiety was found within a sample of 37 people with COPD. 
This was slightly higher than figures reported in other studies (e.g. Karajgi et a l, 1990), which may 
have reflected biases in the sample, and different assessment tools.
2. More severe catastrophic thoughts were related to higher levels of both generalised anxiety, and 
anxiety ratings on the IBPQ. This relationship was particularly strong when situations in which 
symptoms were presented were "unsafe', indicating that the perceived safety of the environment may 
be an important moderator for catastrophic thinking.
3. Catastrophic thoughts were significantly predictive of anxiety, regardless of the severity and 
duration of illness. This relationship was more significant for anxiety ratings on the IBPQ than for 
HADS anxiety. Therapeutically, assessment of cognitions and anxiety specifically related to the 
respiratory disease is important, as more general measures of anxiety may not reflect the true extent 
of the emotional impact associated with COPD.
4. Greater avoidance of 'unsafe' situations was found than of 'safe', and may indicate unrealistic 
appraisals by patients of their true physiological state. Unrealistic catastrophic thoughts about 
consequences of becoming ill in situations away from the home environment or when alone may 
greatly impact on patients' quality of life, in an attempt to control for unnecessarily high levels of 
anxiety. For this reason, therapy should aim to elicit cognitions, and through cognitive 
restructuring, modify thoughts that may be unrealistic and catastrophic.
5. Less satisfaction with social support was significantly predictive of greater generalised anxiety, 
demonstrating the need for other Actors in addition to cognitions to be addressed in therapy with 
people with COPD and severe anxiety.
6. The findings of this study need to be replicated with a larger sample of patients with COPD, and 
include evaluation of other variables that may affect severity of catastrophization and anxiety.
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APPENDIX I - Letter to 6 people who took 
part in initial investigations
Dear
Study of people's mood and feelings about their breathing problems
I am a Trainee Clinical Psychologist based at the Hospital in , with
, Chief Executive. I am currently carrying out a study looking at the 
mood and feelings people have in relation to their breathing problems, and how it 
may affect their life in general. We hope that this information will help in our 
understanding more about the experience of our patients.
Each person who wishes to take part would meet with myself, for up to 1 hour, 
either at the Hosptial, or if it is more convenient, I can visit people in their 
homes. This meeting would be relaxed and informal, and I will be asking questions 
about how people feel about their breathing problems, and how they affect 
everyday life. People will also be asked to fill in a short questionnaire.
I was given your name by , who was involved in running the Pulmonary
Rehab. Group. If you would like to take part, please sign the form overleaf, and 
return it in the stamped addressed envelope, and I will contact you within the next 
week. All information will be anonymous and confidential, and you will not be 
identified in the report of the study. You are free to decide not to take part, and may 
leave the study at any time without it affecting vour medical care. I have discussed 
the study with Dr, , Consultant General Physician, who is happy to
support iL The study itself is subject to strict ethical regulations.
If you would like more information about any aspect Of this study, then please do 
not hesitate to contact me at the above address.
Many thanks. 
Yours sincerely
Karen Sutton
Trainee Clinical Psychologist Chief Executive
(Supervisor)
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APPENDIX il - Consent form
C o rée  No. 95-234
Consent Form
Study of People’s Mood and Feelings about their Breathing Disorder 
Please complete this sheet.
Have you read the information letter? Yes/No
Have you had an opportunity to ask questions and discuss the study? Yes/No
Have you received enough information about the study? Yes/No
If your answer is ‘No’ to any of these questions, and you feel you would like some 
more information before agreeing to take part in the study, then please tick below
and I will be happy to contact you. Tick h ere .............
Do you understand that you are free to leave the study:
-a t any time,
- without having to give a reason for leaving
- and without affecting your medical care? Yes/No 
Do you wish to take part in the study? Yes/No
Signed:__________________________  Date:
Name (in block letters):_______________________
(If you wish to take part, and you do not mind being contacted by phone, please 
write your number below so I can contact you more easily. Thank you ).
Phone number:
‘ ■: ■ . " ■ ’ ■ . ^ . ■ >. ■ ■ • . ■ ,77
APPENDIX rn - Letter to potential 
participants for main study
I can b e  contacted on:
Date:
Dear
Study of people’s mood and feelings about their breathing problems
I am a Trainee Clinical Psychologist based at the - Hospital in
with , Chief Executive. I am currently carrying out a study looking at the
mood and feelings people have in relation to their breathing problems, and how it 
may affect their life In general. We hope that this information will help in our 
understanding more about the experience of our patients.
The study would involve each person who agrees to take part, completing 5 short 
questionnaires. These usually take about 45 minutes in total, and can be done 
either at the chest clinic, or at home if this is more convenienL I will be present to 
answer any questions or concerns people may have while they are answering 
questionnaires.
The names of patients who attend the Chest Clinic here in . , have been
forwarded to me as people who may be suitable to take part in this study. If you 
would like to take part, please sign the form overleaf, return it in the envelope 
provided, and I will contact you within the next week. If you decide not to take part, 
please return the form anyway and I will not contact you again. All information will 
be anonymous and confidential, and you will not be identified in the report of the 
study. You are free to decide not to take part, and may leave the study at any time 
without it affecting vour medical care. I have discussed the study with Dr. ,
Consultant General Physician, who is happy to support iL The study itself is 
subject to strict ethical regulations.
If you would like more information about any aspect of this study, then please do 
not hesitate to contact me at the above telephone number, (if I am not there, please 
leave a m essage and your telephone number, and I will phone you back as soon as 
possible).
Many thanks. 
Yours sincerely
Karen Sutton
Trainee Clinical Psychologist (Supervisor)
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APPENDIX TV - Reminder letter 
to people who did not renlv to original letter
Date:
Dear
I wrote to you recently to ask if you would like to take part in a study which is looking 
a t the relationship between anxiety and thoughts in people with a range of breathing 
disorders. I am writing to everyone who so far has not replied to my original letter. 
As I have not heard from you as yet, I was wondering if you would like to take part, or 
whether you would prefer not to. I would be grateful if you could fill in the consent 
form stating whether or not you wish to take part, and return it in the stamped 
addressed envelope enclosed in the original letter. If I do not hear from you within 
the next fortnight, I will assume that you do not wish to take part in the study.
If you would like further details, I can be contacted on . If I am not there, you
can leave a m essage and I will call you back as soon as possible.
I look forward to hearing from you.
Yours sincerely
Karen Sutton
Clinical Psychologist in Training
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SiiBwnarv of Interview for Initial Investigation 
(for development of IBPQl
1. General information:
Age, sex, diagnosis, duration of illness, frequency of severe breathing difficulties, and 
medication.
2. Frequency of experiencing the following symptoms (taken from the ‘Asthma Symptom 
Checklist’ and the ‘Bronchitis and Emphysema Symptom Checkhst’):
Chest pain, numbness, tightness in chest, chest congestion, shortness of breath, hard to 
breathe, wheezing, chest ‘filling up’, tiredness, exhaustion, no energy, weakness, a lot of 
mucous, coughing, feeling of chest being over expanded, needing fresh air.
3. Any thoughts that the person may have when they experience any of the symptoms above.
4. Direct question:
Do you ever think ‘I’m going to die’, ‘I’ll cope’, etc?
5. How anxious would you feel if you experienced each of the symptoms above(on a scale of 1 -8).
6. Do you avoid any of the following situations or activities in order to reduce the likelihood of 
experiencing an episode of breathing difficulty?
Being alone, drinking alcohol, smoking, going out with friends, walking for 5 minutes, 
walking for 10-20 minutes, going upstairs, travelling alone by bus etc, being in a crowd, 
going out alone, not having medication close at hand, exercise, drinking coffee..
Are there any other situations you avoid?
Appcimixvi
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Interpretation of Breathing Problems Questionnaire
This questionnaire has been developed specifically for people with breathing problems 
including asthma, bronchitis and emphesema. It is designed to assess peoples’ 
thoughts in response to various symptoms they experience as a result of their breathing 
problem.
Here are some descriptions of some of the symptoms you may experience in relation to 
your breathing problem. A variety of situations are described in which each symptom 
may be experienced. Read each one, and then answer the questions below it very 
briefly. Write down the first thing that comes into your mind without thinking too 
long about it. You may not have experienced all of the symptoms or the situations 
described in the questions. If this is the case, please answer the question anvway, by 
imagining how you would respond to the symptom in the situation described.
Each question also asks you to rate how anxious you think you would be in each 
situation, and what you believe could happen to you. Ratings are made on a scale of 
1-10, and instructions on how to respond are given for each question.
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1. You are in a smokey pub and your chest begins to feel tight.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
i------------- i ________ 3________ 4________ s 6_____ 7_____ 8_____ 9_____ 10
e x tre m e ly
a n x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
i-------- 2_____ 3_____ 4 5 6_____ 7_____ 8^_____9_____ 10
I  w ould  ^  be  I .vou ld  b eco m e
® e x tre m e ly  ill
2. How much do you believe you would die in this situation?
i_____ 2_____ 3_____ 4_____ 5_____ 6_____ 7_____ 8_____ 9_____ 10
A b so lu te ly  n o  I  d e f in a te lv
ch an c e  o f  dy in g
Would you avoid this situation?...................................................yes / no
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2. You are at a friends’ house, and your chest begins to feel tight
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
i-  2_____ 3_____ 4_____ 5_____ 6_____ 7_____ 8_____ 9_____ 10
n o  a n x ie ty  e x tre m e ly
an x io u s
Please answer the 2 questions below by marking each scale;
1. How much do you believe you would become ill in this situation?
I-------- 2 3 4 5 6 7 8_____ 9_____ 10
I  ^ o u l d n o t b e  I  w ou ld  b ecom e
e x tre m e ly  ill
2. How much do you believe you would die in this situation?
1 10
A b so lu te ly  n o  j  w o u ld  d e f in a te lv
c h a n c e  o f  d y in g  djg
Would you avoud this situation?................................... yes / no
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3. You are going up the stairs at a shopping centre and you notice it is 
becoming harder to breathe.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious vou would be in this situation, bv marking the scale below:
1_______ 2_______ 3_______ 4_______ 5_______ 6_______ 2_______ g_______ 9_______ 10
no anxiety extremely
an x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation'^’
j________2_______ 3_______ 4_______ f_______ f,_______ 7_______ 8_______ 9_______ 10
I would not be I would become
ill at all extremely ill
2. How much do vou believe vou would die in this situation*^
1_______ 2_______ 3_______ 4_______ 5_______ 6_______ 7_______ 8_______ 9_______ 10
A b so lu te ly  no  I w ould  d e fin a te ly
ch an c e  o f d y in g  die
Would you avoid this situation?.................................... yes / no
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4. You are in a crowd in town, and you begin to feel tired and 
exhausted.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
 -------- 2_____ 3______  5_______ 6_______ 7_____ 8_____ 9_____ 10
e x tre m e ly
an x io u s
Please answer the 2 questions below by marking each scale:
. 1 How much do you believe you would become ill in this situation?
i_____ 2_______ 3_______ 4_______ 5_______ 6_______ 7 8 9 10
I  w o u ld  a m  be  I  w ou ld  beco m e
e x tre m e ly  ill
2. How much do you believe you would die in this situation?
1—i---- 2_______3_______d_______&______ 6_______7_______ 8_______ 9_______10
A b so lu te ly  n o  I  w ou ld  d e fm o te lv
c h a n c e  o f  dxnng
Would you avoid this situation?............................. yes / no
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5. You are going up the stairs at home, and you notice it is becoming 
harder to breathe.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
i ^  4 5 6________7 8________9________ 10
n o  an x ie ty  e x tre m e ly
an x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
i  2 I  ^________ 5________ 6________ 7________ 8________ 9________ 10
I  ^ o u l d n o t b e  I  w ou ld  becom e
ex tre m e ly  ill
2. How much do you believe you would die in this situation?
1 10
A b so lu te ly  no  I  w o u ld  d e fin a te lv
c h a n c e  o f  d y in g  j j g
Would you avoid this situation?...................................yes / no
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6. You are sitting at home with a friend, and you notice you are 
wheezing.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
•*------------- =-------------a -------------4 5 6 7 8________ 9________ 10
e x tre m e ly
an x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
i  2-------------3 4 5 6 7 8 9  m
I  w ou ld  p t  be  I w ould  b ecom e
*“  e x tre m e ly  ill
2. How much do you believe you would die in this situation?
i ------------- 2________ 3________ 4________ 5________ 6________ 7________ 8________ 9________ 10
A b so lu te ly  n o  I  w ould  d e f in a te lv
c h a n c e  o f  d y in g
Would you avoid this situation?...................................yes / no
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7. You are driving down the motorway, and you notice your chest is 
becoming congested.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
1_--------- 2 3 4 5 6 7 8 9 10
n o  an x ie ty  ex trem e ly
an x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
j  2 3 4 5 6 7 8 9  10
I  w o u ld  n o t be  I  w ould  becom e
ex trem e ly  ill
2. How much do you believe you would die in this situation?
1 10
A b so lu te ly  no  j  w ould  d e fin a te lv
c h a n c e  o f  d y in g  j j g
Would you avoid this situation?.................................... . .yes / no
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8. You are at your G.P. surgery, and you begin to cough heavily.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below;
nu a n n e tv
 10
e x ire m e ly
an x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
10
I  w ould  p  be 1 w ou ld  b ecom e
e x tre m e ly  ill
2. How much do you believe you would die in this situation?
i -------------1________ 1________ é________ 5________ 6________ 7________ 8________ 9________ 10
A b so lu te ly  no  I  w o u ld  d e f in a te lv
c h an c e  o f  d j in g
Would you avoid this situation?.................................. yes / no
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9. You are visiting a physiotherapist at the hospital, and you feel your 
chest is becoming congested.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
i  2________ 2________ é.________ 5________ 6________ 7________ 8________ 9________ 10
no  anxiet} ' e x tre m e ly
an x io u s
Please answer the 2 questions below by marking each scale:
T How much do you believe you would become ill in this situation?
j ________ 2________ 3________ 4________ 5________ 6________ 7________ 8________ 9________ 10
I  w ould  n o t be I  iivouid becom e
ill a t a ll^  e x tre m e ly  ill
2. How much do you believe you would die in this situation?
1 2 2 4 S 6 7 8 9 10
A b so lu te ly  no I  w o u ld  d e f in a te lv
c h an c e  o f  d y in g  d ie
Would you avoid this situation?................................... yes / no
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10. You are on a crowded bus and you notice you are wheezing.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
1-------------2________ 3________ 4________ 5________ 6________ 7________ 8________ 9________ 10
n o  a n x ie i)  e x tre m e ly
anxiuus
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
1-------------2________ 3________ 4________ 5________ 6 7 8________ 9________ 10
I would not be I would become
ex tre m e ly  ill
2. How much do you believe you would die in this situation?
i ________ 2________ 3________ 4________ 5 ■ 6 ________ 7 '  8________ 9 10
A b so lu te ly  n o  I  w o u ld  d e f in a te lv
c h a n c e  o f  dy in g  djg
Would you avoid this situation?..................................yes / no
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11. You are out working in your garden with a friend, and you notice 
you are short of breath.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below;
i  2________ 3________ 4________ 5________ 6________ 7________ s  9________ u )
no a n x ie ty  e x trem e ly
an x io u s
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
I  w o u ld  n o t be I w ould  becom e
e x tre m e ly  ill
2. How much do you believe you would die in this situation?
1_____ 3________ 3________ 4________ 3_____ 6_____ 7_____ 8______9_______ J O
A b so lu te ly  no  i  w ould  d e fin a te lv
c h an ce  o f d y in g  die
Would you avoid this situation?..................................yes / no
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12. You are in the supermarket, and you begin to cough heavily.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
 2-----------------  4________ 5________ 6________ 7________ 8 9________ 10
n o  an x ie ty  cx ire m e ly
anxious
Please answer the 2 questions below by marking each scale:
L How' much do you believe you would become ill in this situation?
J ------------- =------------- 5------------- 4________ 5_ 6 7 8 9 10
I w ould  becom e 
e x tre m e ly  ill
2. How much do you believe you would die in this situation?
_  ,-- -------------- --------------^ i ________ 5________ 6________ 7________ 8________ 9________ 10
A b so lu te  y  no  I  w o u ld  d e fin a te lv
c h an c e  o f d y in g  ----------------
Would you avoid this situation?......................................yes / no
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13. You are at the hospital for a check-up, and you begin to feel tired 
and exhausted.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below:
10
ex trem e ly
anx ious
Please answer the 2 questions below by marking each scale:
1. How much dp you believe you would become ill in this situation?
i ----------- 2_______ 3_______ 4_______ 5_______ 6 7_______ 8_______ 9_______ 10
I  w o u ld  n o t be  I w ould  becom e
extrem ely ill
2. How much do you believe you would die in this situation?
i  2_____ 3 4 • 5_______ 6_______ 7_______ 8_____ 2_____ 15
A b so lu te ly  n s  I w ould  definn fe ly
c h a n c e  o f  dy in g  d ie
Would you avoid this situation? ye§ / no
14. You are out on a long walk on your own, and you notice you are 
short of breath.
What might you do in this situation?
What thoughts go through your mind?
What is the worst thing that you think may happen to you?
Please rate how anxious you would be in this situation, by marking the scale below;
i_______ 2_______ 3_______ 4_______ 5_______ 6_______ 7_______ 8_______ 9_______ 10
no  anx ie t}  ex trem ely
anxious
Please answer the 2 questions below by marking each scale:
1. How much do you believe you would become ill in this situation?
10
I  w o u ld  n o t be  I >vould becom e
ill a t  all ex trem ely  ill
2. How much do you believe you would die in this situation?
1 2 3 4 5 6 7 8 9  10
A b so lu te ly  n o  I  w ould  d e fin a te lv
c h a n c e  o f d y in g  d ie
Would you avoid this situation? yes / no
Thank vou for completing this questionnaire - please check through it 
to ensure vou have answered all 14 questions as pages often stick 
together!
Hospital Anxiety and Depression Scale
Hospital Anxiety and 
Depression Scale (RADS)
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I
I  Name: Date:
Clinicians are aware that emotions play an important part in most illnesses. If your 
clinician knows about these feelings he or she will be able to help you more.
This questionnaire is designed to help your clinician to know how' you feel. Read each 
below and underline the reply w'hich comes closest to how you have been feeling 
in the past week. Ignore the numbers printed at the edge of the questionnaire.
Don’t take too long over your replies, your immediate reaction to each item will 
probably be more accurate than a long, thought-out response.
A p
T
_2^
=L - 
0
[OJ
m
u
m
a
I feel tense or ‘wound up’
M ost of  the  time
A lot of  the  time
From time to time, occas iona l ly
Not a t all
I s t i l l  en jo y  th e  t h i n g s  I u s e d  to  en jo y  
Definitely as  much 
Not quite  so much 
Only a lit tle
■ Hardly  at all
I g e t  a  so r t  o f  f r ig h t e n e d  fe e l in g  a s  if
s o m e th in g  aw fu l  is a b o u t  to h a p p e n
\ 'e r \  definitely  a h d  qu ite  bad ly  
Yes. but n e t  too bad ly  
A little, bu t it d o e s n ' t  worr}' me 
Not a t all
I c a n  la u g h  a n d  s e e  th e  f u n n y  s id e  o f  t h in g s  
.As much a s  I a lw ays  could  
Not quite so much now  
Definitely no t  so m uch  now  
Not a t  all
W o rry in g  t h o u g h t s  go  th r o u g h  m y  m in d  
A g rea t  deal of  the time 
A lot of the  time 
Not too often  
Very little
I feci ch e e r fu l  
Never 
Not often 
Som etim es  
M ost of  the  time
I can sit at ease and feel relaxed
Definitely 
U sual ly  
Not often 
Not a t  all
3
c
I feel a s  if  I a m  s low ed  d ow n
Nearly all the time 
Very often 
Som etim es 
Not a t  all
I g e t  a s o r t  o f  f r ig h te n e d  fee ling  like  
b u t t e r f l i e s '  in th e  s to m a c h  
Not a t all 
Occasionally 
Quite often 
Very often
I h a v e  lo s t  in te r e s t  in m y a p p e a r a n c e
Definitely
1 d o n ' t  take as  much care as I should  
1 m ay not take quite  as  much care 
I take just as  much care as ever
I feel r e s t l e s s  a s  if 1 h av e  to b e  on
th e  m ove 
\ 'e ry  much indeed 
Quite a lot 
Not very much 
Not a t  all
I lo o k  fo rw a rd  w i th  e n jo y m e n t  to t h in g s  
As much as I ever did 
R a the r  less than  1 used to 
Definitely less than  1 used to 
Hardly a t  all
I g e t  s u d d e n  fee l ings  o f  p a n ic  
Very often indeed ■- 
Quite often 
Not very often  
Not a t  all
I c a n  e n jo y  a  g o o d  b o o k  o r  ra d io  o r  
te le v is io n  p r o g ra m m e  
Often 
Som etim es 
Not often 
Very seldom
Now check that you have answered all the questions
This form is printed in green. Any other colour is an unauthorized photocopy. 
H.VDS copyright vR .P . Snaiih  and A.S. Zi.um ond..i‘.*S3.
TOTAL
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APPENDIX V m
Scoring Bands for the HADS
Range of scores 
0-7
8-10
11-14
15-21
Interpretation 
. normal
mild
moderate
severe
Snaith and Zigmond (1994)
It should be noted that althought these definitions were used in this study, the HADS may now be 
interpreted in clinical situations in the following way;
0- 7 no anxiety 
8-10 possible anxiety 
11+ probable anxiety
11 :
APPENDIX IX 
S t Georges Hospital Respiratory Questionnaire
This short questionnaire is designed to help us learn more about how your breathing is 
troubling you. Please read the instructions carefully, and ask if you do not understand 
anything. Do not spend too long thinking about your answers.
Thank you.
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Questio ns a bo ut  how  m uch  c h est  tr o u b l e  y o u  h ave  h a d  over  the last  year , p l e a se  tic k  in  o ne  
BOX FOR eac h  questio n .
most several a few only with . not 
days days days a chest at 
a week a week a month infections all
1) Over the last year, I have coughed ; O
2) Over the last year. I have brought 
up phlegm (sputum) :
3) Over the last year, I have had
shortness of breath :
4) Over the last year, I have had attacks 
p f wheezing :
5) During the last year, how many severe or very
unpleasant attacks of chest trouble have you had :
O
O
o
I ' 
\
: . 
Li
c
i 8) If you have a wheeze, is it worse in the morning:
O
O
0
0
0
0
O
0
o
o
o
o
o
o
o
o
6) How long did the worst attack of chest trouble last: 
(Go to Question 7 if you had no severe attacks)
7) Over the last year, in an average week, how many good days 
(with little chest trouble) have you had: ,
more than 3 attacks............................ O
3 attacks  ............................ . O
2 attacks......................................   O
1 attack..............................................  O
no attacks..........................................  O
a week or more.................................  O
3 or more days..................................  O
1 or 2 days......................................   O
less than a day. ............    O
none...................................................  O
I or 2.................................................  O
3 or 4..................................      O
nearly every day...............................  O
every day..........................................  O
no ..................   O
yes..............................  O
I :
SHORT FORM SOCIAL SUPPORT 
QUESTIONNAIRE (SSQ6)
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Name:
Age: Sex:
Instructions
The following questions ask about people in your environment who provide you with help or 
support. Each question has two parts. For the first part, list all the people you know, exclud­
ing yourself, whom you can count on for help or support in the manner described. Give each 
person’s initials and their relationship to you (see example). Do not list more than one per­
son next to each of the numbers beneath each question. Do not list more than nine people 
per question.
For the second par:, using the scale belcw, circle hew satisfied ycu are with the overall sup­
port you have.
6
V e ry
s a t is f ie d
r a i r i y
s a t is f ie d
4 .• 
A  U nie  
s a t is f ie d
A  '.idle  
d is s a t is f ie d
r a i n y
d is s a t is f ie d
1
V e r y
d is s a t is f ie d
If ycu have no support for a question, tick the words 'No one’, but stiil rate ycur level of sat­
isfaction.The example below has been completed to help you. All ycur responses will be kept 
confidential.
Example
Who do you know whom you can trust with information that could get ycu in trouble?
(a) No one
1) T é lv I ^ S r o r h e r )  
t m
(b) How satisfied?
3) FlSS (FnW ] S) 
LrA (Srnpiouer)
9)
—    ;    ^ _ 2 ^     -----------------------------
(1) Whom can you really count on to distract you from your worries when you feel under stress?
(a) No one 3) 6) 9)
1) 4) 7)
2) 5) 8)
(b) How satisfied? 1
(2) Whom can you really count on to help you feel more relaxed when you are under pressure or 
tense?
(a) No one 3) 6) 9)
1) 4) 7)
2) 5) 8)
(b) How satisfied? 6 5 4 3 2 1
(3) Who accepts you totally, including both your worst and best points?
(a) No one 3) 6)
1) 4) 7)
2) 5) 8)
(b) How satisfied? 5 c 4 o
S)
(^) Whom can you really count cn tc care accut you. regardless of what ;s happening to ycu? 
(a) No one 3} 5) 91
1) 7)
2) 5) 8)
(b) How satisfied? 5 5 4 3 2
(5) Whom can you really count on to help ycu feel better when you are feeling 
generally down-in-the-dum.ps?
(a) No one 3) 6) S)
1) 4) 7)
2) 5) 8)
(b) How satisfied? 6 5 4 3 2
(6) Whom can you count on to console you when you are very upset?
(a) No one 3) 6) 9)
1) 4) 7)
2) 5) ' 8)
(b) How satisfied? 6 5 4 3 :
Scdal Psychology. 44 ,1 2 7 -3 9 . Reproduced with the kind permission of the authors.
This measure is part of Measures in Health Psychology: A User's Portfoiio, written and compiled by Professor John 
Weinman, Dr Stephen Wright and Professor Marie Johnston. Once the invoice has been paid, it may be photocopied 
for use within the purchasing institution only. Published by The NFER-NELSON Puolisriing Company Ltd, Darville 
House, 2 Oxford Road East, Windsor. Berkshire SL4 IDF, UK. Code 4920 05 4
APPENDIX XI g g
Background Information for Research
Name/Code..................................... Date.................................................
Age.................................................. D O B ......................... Sex M /F
Referred Through:......... ........................... ................................................................
Diagnosis.
Duration of Illness.
Medication.
Total number o f visits to hospital/casualty for illness.
Visits in last year  Average duration of visits.
Questionnaires completed:
Breathing Problems Qu.
IPQ
HADS
St. Georges Qu. 
‘SafeV’Unsafe’ Ratings
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APPENDIX XTÏ 
Original Ethics Proposal
The original proposal to the ethics committee was made before the IBPQ had been developed. 
Consequently, subsequent ammendments were made to this proposal which are outlined in 
\  Appendices Xm to XV. Part of the title on the original proposal was changed from 
‘misinterpretations of bodily symptoms’ to ‘catastrophic thoughts’ as this was felt to be rather less 
misleading with regards to the aim of the study.
\
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CENTRAL OXFORD RESEARCH ETHICS COMMITTEE FORM CONFIDENTIAL
Valid Until Ju h  1995
Please complete using a typewriter 
or printer that keeps this layout,
1. Title of Studv
COREC number
The relationship between anxiety and misinterpretations of bodily 
symptoms in pa tients with' chronic pulmonary disease.
2. Principal InvestigatorCs)
1. 2. 3 . 4. I
Names Karen Sutton Louise Walla (Supervisor)
ce i
1
1
Qualifications BSc Psychol. 
(Hons)
BSc, MSc, 
PhD, MBa, 
KBPS (Psvcho1).
1
Position TraineeClinical
Psvcholozist
Chief
Executive I!i
Employing Authority 
Contract
(none,hon,full,P/T)
Oxford Reg. 
Heslth Auth. 
(full)
Hospital 
NHS Trust 
(full)
t
i!!
!1
3. Address for correspondence (the Principal investigator is responsible for keeping the other 
investigators informed) __________________________________________
Karen Sutton, Oxford Regional (in Service) Training Course in Clinical 
Psychology, Isis Education Centre, Warneford Hospital, 
Headington, CX70RD.
4. Work & Home Teienbone numbers for enauiries
Work: 01365 226451. Home: 01491
Hosoital.5. Where will the research be done?  __ .  ^_ .
Is the study to be multi-centre?
6. Has this application gone to other Ethics Committees?
7. When would the study start and finish? October 1995 - July 1996
8. What arrangements have been made for indemnity?
8a. If the scudy has dnig-company hmding, has rhe company signed die
standard indemnity letter from your employing authority (see note below)?
8b. If you are employed in an NHS Trust, has it agreed to indemnifv vou for dus research 
— ^Honorary Contract to be issued by Ten. Hospital.
8c. If you are employed by the University, has it agreed :o indemnity’ you for ±is research?
8d. If you are self-employed, or the answers to 3a, 3b and 3c are no. what is your medical indemnity?
Yes,%)
Yes/(%
Yes/No
( ^ N o
Yes/No
The letter o f agreement between your employers and a drug company should follow the ABPI guidelines, and 
it must be signed by both your employer and by^  r/zf comnnw.j; mnv be obtained from
Trust Chief Executives/Medical Difeciors.'^A^com^'of/fhei^Tndemnlr^l^efMhduld^be^se'nr^GO ‘
T ^
N.B. Chronic Obstructive Pulmonary Disease = COPD 
9. Scientific background of the study__________• _______________
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Research suggests that patients suffering from COPD experience higher thar 
average levels of anxiety and depression, (Lehrer et al,1992). Causality 
of anxiety is likely to be part of a complex mechanism mediated in some 
patients by misinterpreting certain normal bodily functions as indicators 
of an imminent breathing difficulty related to COPD, (Paul Bennett, perso: 
communication).
Physical exercise rehabilitation programmes hsve a significant impact on 
the quality of life of these patients . (Petty,T. 1995). There is also 
evidence that additional psychological -approaqhes can significantly reduc 
illness-related anxieties (Lehrer et al, 1992). Identification of the 
factors involved in the mediation of anxiety in pulmonary patients is 
therefore highly important in setting up an effective management programme 
to complement existing rehabilitation services.
10. Has a similar study been done previously? Yes/^^ If yes, why repeat if
11. Purpose of project, in terms that a non-medic could understand._________
The aim of this study is to see if there is a relationship between high-
levels of anxiety in some patients with COPD, and frequent misinterpretin
of normal bodily functions (eg: shortness of breath after exercise)
as a sign of a serious breathing difficulty. If such a relationship exist
patients can be taught to discriminate,between genuine,warning sighs, and 
normal breathing, and hence reduce anxiety levels.
12. Design of study (a summary of the protocol, including the reasons for ±e number of subjects in Q 13)
1 .Development of misinterpretations questionnaire: 5 participants who 
consent, will be informally interviewed in order to ascertain common 
thoughts.and worries relating to their illness. The information will be 
incorporated in a questionnaire based on the ’Interpretations Question-' 
naire' enclosed (see page 10). The HADS will also be given for completi
2. Main Study: With the agreement of the consultant Physician, a minimum c 
50 adult outpatients attendingjrespiratory clinics will be given informât 
about the study. The principal investigator will meet with each patient 
who consents to take part to discuss any queries they may have, on an 
individual basis. The questionnaires will then be presented, and partie 
pants asked to jomplete them. Again, the Investigator will oe present 
if there are any queries. This will be carried out either at routine 
outpatient appointments at the clinic, or in the participants home if 
this is more convenient. All questionnaires will be coded for anonymity
and kept in a locked filing cabinet at the Horton Hospital.
3 «Test-Retest reliability of the misinterpretations questionnaire: The 
questionnaire will be sent to each participant to be filled in again,
4 weeks after they originally completed the initial battery of tests.
■Questionnaires can be returned by pre-paid postage.
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13. SUBJECTS
Healthy people • Patients Control Patients
Number to be 
studied / 50. / .
Inclusion
criteria / People with COPD (including asthma, emphesema, etc) 
All=outpatients
Exclusion
criteria / People with additioj serious physical or mental health problems. lai /
Age range 
Males : 
Females ; / 18 -80 years equal male;female if possible. /
Method of 
recruitment 7 Patj enLs attenoing respiratory clinics - opt-in procedure 
after info, sheet p
/
resented.
14. I\Tiat procedures will the subjects have? Include exercise tests, ECGs, catheterisation, X-rays 
lasers, ultrasound, microwaves, shortwaves, M RI and radio-isotopes, and state the estimated risk 
from these procedures. ____________________ ________________ __________________________
Participants will be asked to complete 3 questionnaires. These will be 
completed in a quiet room to maintain confidentiality, or in the person's' 
home if, they prefer. Completion of the questionnaires should take up to 
30 minutes, and the principal investigator will be present to answer 
questions participants may have. Additionally, the misinterpretations 
questionnaire will be sent to participants 4 weeks after the original 
completion, to assess test-retest reliability over time.
There is NO estimated risk from this procedure.
15. WTiat samoles will be taken extra to normal care? Do anv carr*/ risks?
16, W hat events or m easurements will be the main endpoints in your study?
Scores on each questionnaire for each participant will be entered into a 
regression analysis.
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Information and Consent 
Please read the notes carefidly when answering this section.
21. Who will give the verbal explanation of the study to the subject? _________  ___
Principal Investigator, Karen Sutton.
Please append the letter inviting subjects to take part and explaining the study, as it will appear - i.e. using 
your letterhead, etc. I f  there is no written invitation and explanation, please Jusdjy.
22. How long will the subject have between the explanation and being asked to take part? If  less than 
24 hours, please Justify._____________________________________________________________________
Minimum 1 week.
23. Will you use the Royal College of Physicians’ consent form? 
: If not, olease exoiain
24. Do you have the agreement of other doctors and nurses involved in the care of the patients?,,.^
(^N o
Please attach the letter to the subjects ' general practitioner. (Please see page 10)
25. Please say what funds will be used and who will be paid for the study, and state the payment per. 
patient if this is the method of funding___________ ________ _________________________________
Questionnaires will be funded by a budge: held by zhe Oxford Reg. Training 
Course. There will be no other overheads.
The principal investigator must sign that he or she
* affirms that the information in this application is t ’jc .
* understands the obligations to, and i e  rights of, the iubiects, pardculariy in giving of informaiior 
and obtaining of consent.
* and will ensure diat the patient's hospital medical records ire marked say ±at ±e  panent is in z 
study, giving the title and COREC number for reference
26. Signature:
Date; 'Z Q  / c \  /  ^  $ _________
NAME in CAPITALS ^  W
 ^ 27. C o n s u l ta n t /H e a d  o f  D e p .\r tm e n t:  should sign that he or she has discussed the research 
aoDlication with the investigator, and suooorts the aDolication. _______
yV  Signature: , u
vyC  Date: Please see attached memorandum from Louise Wallace. ‘^-7^
NAME in CAPITALS:
u
I -
/ T>PFNrnTX xm
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Initial reply from ethics committee, following discussion 
with committee member to explain details of study
CENTRAL OXFORD RESEARCH ETHICS COMMITTEE
Oxfordshire Health 
Directorate o f Public Health & Health Policy 
Manor House, Headley Way 
Headington, OXFORD 0X3 9DZ 
% , Tel: Oxford (01865) 222547
Fax: Oxford (01865) 222777
Please reply to Miss Ellen Hearth
Our Ref: RMW/EH/PS/95-2 34
Your Ref:
17th October 1995
Ms Karen Sutton
Trainee Clinical Psychologist
Oxford Regional (in Service)
Training Course in Clinical Psychology 
Isis Education Centre 
Warneford Hospital
Dear Ms Sutton,
RE: COREC: 95-234 - The relationship between anxiety and
misinterpretations of bodily symptoms in patients with chronic 
pulmonary disease
 ^ has told me about his discussion with you on this
proposed research. It appears that COREC did not understand the 
background to the questions that you proposed to put to patients with 
C.O.P.D. I gather that you are modifying the questions. If you would 
send me the revised questionnaire, with some more information about the 
validity of the questions, I shall see if I can give you Chairman's 
approval as soon as possible.
Yours sincerely,
c M .
Dr R Mayon-White ^ ^
Vice Chairman
Central Oxford Resesrch Ethics Committee
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APPENDIX XIV
Letter granting ethical approval, following 
submission of EBPO
OXFORDSHIRE HEALTH
OXFORDSHIRE HEALTH AUTHORITY 
OXFORDSHIRE FAlVOLY HEALTH SERVICES AUTHORITY
CENTRAL OXFORD RESEARCH ETHICS COMMTTTEI 
Stable Block, Headley Way, Headington, Oxford, 0X3 9D>
Tel: 01865 22254: 
Fax: 01865 22277:
Our Ref: RC/KLB/FS/95.234
22nd January 1996
Ms Karen Sutton
Trainee Clinical Psychologist
Oxford Regional (in Service)
Training Course in Clinical Psychology 
Isis Education Centre 
Warneford Hospital
Dear NIs Sutton,
RE: COREC:—95.234 - The relationship betw een anxietv and m isinterpretation * of 
bodily svmT?tonis in patients w ith  chronic pulTnonarv disease
Thank you for letting me have the further details on this project I am happy to confirm 
ethical approvaL and wish you every success with the study. I would be very grateful if 
you could send me a copy of any publication which may arise from this study.
You should inform COREC of any adverse affects or events. In addition, if the
investigators do not follow the protocol, or have protocol changes, but fail to inform
COREC, then the Ethics Committee approval will be w ithdraw n and will no longer be 
binding.
Y^urs ^ c e re ly ,
Dr R Chapman 
Consultant Phyacian 
Chairman
Central Oxford Research Ethics Committee
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APPENDIX XV - 
F u rth e r  changes to original ethics Applications
Following the letter (22nd January, 1996) giving ethics committee approval for the study to go 
ahead using the IBPQ, three further letters were sent to the committee, each asking for (and 
receiving) approval for specific changes. Due to shortage of space, I have summarised these 
applications - for copies of actual letters, please contact the author.
1. 11/2/96:
(i) Changes to format of original IBPQ
(ii) Application for open-ended responses on IBPQ to_bejudged^byJndependent-rateFS- 
~  “ (ïiî). Application for use oTthe St. Georges Respiratory Questionnaire, with information
on reliability and validity.
Approval received: 21/2/96.
2. 21/2/96:
(i) Application to send ‘reminder letter’ to people who had not replied to original. 
Approval received: 28/2/96.
3. 4/4/96:
(i) Application to use Short Form Social Support Questionnaire-6.
Approval received: 12/4/96.
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APPENDIX - Cover letter to participants 
who agreed to take part in the retest-condition
Dear
Following my visit to your house a few weeks ago to complete some 
questionnaires on different aspects of your breathing problem, I am 
sending you one of them to complete again, as you kindly agreed to do 
this when we met. You will probably remember completing the (long) 
Interpretation of Breathing Problems’ questionnaire when I saw you - 
instructions are on the front sheet if you need them. The second 
questionnaire is a measure of your view of the social support you 
receive from family, friends, health professionals, etc. I have included 
it in the study as it has been shown to provide useful information about 
where people obtain most of their support, and can be related to how 
they cope with the breathing problem. I apologise for its late inclusion 
in the study and I hope that you do not mind completing it as well. As 
before, the questionnaires you complete will be totally anonymous and 
you will not be identifiable in any way in the write-up. Instructions for 
completion are on the front sheet, but if you have any problems with 
either this questionnaire, or the other one, please do not hesitate to 
call me on . , and if I am not there, I will phone you back as
soon as possible. I have enclosed a stamped addressed envelope for 
you to return the completed questionnaires in.
109 -
Once again, I would like to thank you for sparing me the time to 
complete these questionnaires and helping me with this study. It 
seem s to be going quite well, and I have particularly enjoyed meeting 
so many people who are willing to share their experiences with me.
I wish you well in the future.
Yours sincerely,
Karen SuLluii
Clinical Psychologist in Training
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APPENDIX X V n 
Rating criteria of open-ended responses 
(severity of catastrophic thoughtsi
1 = Non-catastrophic:
Responses that imply that the participant is not at all worried about the symptom described, 
e.g. T’ll be fine’, T’U cope OK’, ‘Nothing will happen’, etc.
Any response that implies no adverse consequences with regard to symptoms becoming 
more severe.
Reactions reflecting irritation or embarrassment at experiencing problems that inconvenience 
the participant, but not with regards to exacerbation of symptoms, e.g. ‘I’ll find a toilet where 
I can cough without anyone seeing me’, ‘I’ll be late, but I’ll be OK’, etc.
2 = Moderately catastrophic:
Answers implying a moderate consequence with regards to exacerbation of symptoms, e.g. 
symptoms will become worse, but implication that this is not distressing, or that the participant 
is able to cope, e.g. ‘My breathing will become worse’, ‘If I don’t sit down. I’ll become more 
breathless’, etc.
3 = Severely catastrophic:
Answers implying a severe consequence of specific breathing related problems, in which the 
participant clearly expresses a thought reflecting a consequence that may put them in danger, 
e.g. thoughts of collapse, sufifocation, and death.
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APPENDIX X V m
Table 19: Examples of open-ended responses from IBPQ
Category of 
Response
Examples of responses
Non-
catastrophic
T’m OK because the Dr. is here, so even if I get worse I’ll be OK’
T’ll cope because my husband is always here {at home) with me’ 
‘Embarrassed {at wheezing in company), but I’ll take my ventolin and be fine’ 
‘I’ll be alright after a rest’
‘No problems!’
‘I’m in the right place {hospital) if it does get worse’
‘I’ll be OK - I’ve got my medication with me’
‘I’ll ignore it and it will go away’
‘I’ll be OK after a puff {on inhaler)'
‘I’m in safe hands {yvith physiotherapist)'
‘I’ve eaten too much - it’s nothing to^o v^ ith my breathing’ .
RÆlly annoyed - tibis always happens {short of breath) and I’ll be late’
‘Hope no-one notices - embarrassed’
‘Very angry - 1 can’t even do my shopping without coughing’
Moderately
catastrophic
‘I'm going to have a breathing problem’
‘I won’t be able to catch my breath’
‘I must slow down and take my ventolin or it (breathing) will get worse’
‘I’ll get dizzy and breathless’
‘Concerned - I’ll become uncomfortable’
‘I have to get out {of supermarket) because I’m embarrassed and I wouldn’t 
know if it will get worse’
‘My breathing will become worse but I won’t die’
‘Try to calm down - concerned I’ll get worse’
‘Embarrassed and angry - worried I’ll get ill’
‘Worried if I’m alone incase I feel worse’
‘Worried because I’m not at home or with fiiends’
Severely
catastrophic
‘I must get out {of smokey pub) - veiy anxious - I’ll collapse’
‘I’ll stop breathing and get brain damage’
‘I haven’t got much time before I collapse’
‘It {wheezing) will get worse - 1 won’t be able to breathe and I wouldn’t 
any oxygen with me’
‘Can’t breathe - might die’
‘I’ll lose control and no-one can help me’
‘I’ll collapse and go to hospital if I’m lucky’
‘Panic - If I don’t stop the car this’ll get bad and I’ll stop breathing - 
haven’t got much time’
‘The smoke {in the pub) will clog up my lungs and I’ll get ill - panic’
‘I’ll get breathless and pass out’
‘Choke’
‘I’ll need to find a hospital and there may not be one for miles’
‘I may have a serious attack, and no-one around knows how to help me’
T have to get bade home - need a phone to get help before I stop breathing’
have
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Table 20: Tesi-retest reIM)ility data for 18 partidpants- Wîlcoxon's analysis of anxiety scores, 
belief in becoming ill, and belief in dying, for each question.
Anxiety
ratings
z
Belief in 
becoming ill 
z
Belief in 
dying 
z
'Safe* items
Friends house - chest tight -2.58* -0.87 -0.27
Stairs/home - hard to breathe -0.77 -0.53 -0.94
Hospital- tire^exhausted____ __^1.._49__ — ^2.19*— -—--1-7-28—
With Physio - chest congested -0.86 -0.53 -0.27
Home with friend - wheeze -0.15 -0.90 -1.35
GP surgery - cough heavily -0.49 -0.10 0.00
Gardenfriend - short of breath -0.10 0.00 -0.94
* Unsafe’ items -
Smokey pub - chest tight -0.77 -1.33 -0.42
Stairs at shop - hard to breathe -2.10* -1.78 -0.18
Crowd/town - tired/’exhausted -2.04* -1.12 -1.48
Drive mAvay - chest congested -0.59 -0.18 -0.73
Crowded bus - wheeze -0.39 -1.02 -0.25
Supermarket - cough heavily -0.35 -0.51 -0.94
Long walk - short of breath -0.90 -0.71 -0.28
*;t<0.05
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Eigures demonstrating the outlvin? scones of one participant 
for ratines of anxiety on *safe* items on the ÏBPQ
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APPENDIX XXI
Table 21: Correlations of anxiety ratings for each question, with individual HADS scores for (i) all 
37 participants, and (ii) Excluding outlier.
All
participants
(n=37)
Correlation
Coefficient
Excluding
outlier
(n=36)
Correlation
Coefficient
S^afe  ^kertis ^  -
Friends house - chest tight ,0.32* 0.47**
Stairs/home - hard to breathe 0.21 0.39**
Hospital - tired/exhausted 0.28* 0.32*
With physio - chest congested 0.28* 0.48**
Home with friend - wheeze 0.17 0.43**
GP surgery - cough heavily 0.19 0.36*
Garden/friend - short of breath 0.39** 0.64**
‘Unsafe* items
Smokey pub - chest tight 0.50** 0.58**
Stairs at shop - hard to breathe 0.52** 0.62**
Crowd/town - tired/exhausted 0.40** 0.50**
Drive mAvay - chest congested 0.16 0.22
Crowded bus - wheeze 0.47** 0.56**
Supermarket - cough heavily 0.40** 0.52**
Long walk - short of breath 0.42** 0.50**
*p<0.05; **P<0.01
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Table 22: Construct Validity - Catastrophic thought ratings correlated with ratings of anxiety
Open-ended responses 
correlated with ratings 
of anxiety (n=37) 
Correlation coefficient
‘safe* items
Friends house - chest tight 0.53**
Stairs/home - hard to breathe 0.68**
Hospital - tired/axhaustod 0.51**
With physio - chest congested 0.55**
Home with friend - wheeze 0.62**
GP surgery - cough heavily 0.65**
Garden/friend - short: o f breath 0.60**
‘unsafe* items
Smokey pub - chest tight 0.59**
Stairs at shop - hard to breathe 0.65**
Crowd/town - tired/exhausted 0.71**
Drive mAvay - chest congested 0.32*
Crowded bus - wheeze 0.75**
Supermarket - cough heavily 0.73**
Long walk ~ short o f breath 0.81**
*p<0.05; **p<0.01
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Table 23: Concurrent Validity - Correlations of open-ended responses with belief in
becoming ill and belief in dying.
Openended res 
participants) o 
Beliefi'ill 
Correlation 
coefficient
ponses for (37 
orrelated with: 
Behef'dying 
Correlation 
coefficient
‘safe* items
Friends house - chest tight ' 0.38** 0.36*
Stairs/home - hard to breathe 0.57** 0.55**
Hospital - tired/exhausted 0.33* 0.43**
With physio - chest congested 0.57** 0.71**
Home with friend - wheeze 0.62** 0.52**
GP surgery - cough heavily 0.55** 0.76**
Garden/friend - short of breath 0.54** 0.64**
‘unsafe* items
Smokey pub - chest tight 0.48** 0.49**
Stairs at shop - hard to breathe 0.43** 0.33*
Crowd/town - tired/exhausted 0.70** 0.71**
Drive mAvay - chest congested 0.60** 0.57**
Crowded bus - wheeze 0.84** 0.53**
Supermarket - cough héavily 0.69** 0.54**
Long walk - short o f breath 0.82** 0.56**
*p<0.05; **p<0.0^
